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ABSTRACT 
Katelyn R. Houston:  Functional Polyesters for Biomedical and Industrial Applications 
(Under the direction of Valerie Sheares Ashby and Wei You) 
 
Advances in polymer science impact a range of materials applications, from medical 
technology to commodity plastics.  This dissertation describes the development of radiopaque 
biomaterials and supramolecular engineering polymers accomplished via synthesis, 
characterization, and elucidation of the structure-property relationships of functionalized 
polyesters.    
Computed tomography (CT) generates detailed images for diagnosing diseases and 
monitoring implants.  While metallic implants are easily visualized by CT, polymeric implants, 
absent of high Z elements, lack radiocontrast.  Nevertheless, replacing metal-based implants with 
polymeric materials has many advantages: biodegradability, increased biocompatibility, and 
tunable thermal and mechanical properties.  Additionally, blood pool imaging utilizes CT 
contrast agents, which are rapidly excreted and renally toxic.  Designing polymeric biomaterials 
capable of long-lasting x-ray contrast could lead to safer, more effective implants and contrast 
agents.  
In Chapters 2 and 3, a single iodinated monomer was used to synthesize and evaluate a 
variety of aliphatic, radiopaque polyesters.  These polymers exhibited high radiocontrast, tunable 
thermal and mechanical properties, low cytotoxicity, and they were easily processed into both 
nanoparticles and thermosets.  The nanoparticles showed good continual contrast with no uptake 
	 iv 
into the kidneys.  Additionally, copolymer thermosets served as stable, biocompatible and 
degradable, inherently radiopaque shape memory materials. 
While the functionalization of a unique monomer was highlighted in the first part, 
Chapter 4 focuses on polyester endgroup functionalization.  The benefits of supramolecular 
polymers include recyclability, self-healing, and processability.  While the effect of the 
supramolecular ureidopyrimidinone (UPy) endgroup has been investigated on many low-
performing polymers, this moiety has not been broadly investigated with higher performance 
materials.  High molecular weight engineering plastics have excellent mechanical properties, but 
they can be difficult to process.  By end-functionalizing low molecular weight engineering 
polymers with a supramolecular moiety, issues involving processability could be overcome while 
maintaining robust mechanical properties.  Herein, the structure-property relationships of end-
functionalized glycol-modified poly(ethylene terephthalate) (PETG) of various molecular 
weights were investigated using the UPy group and various linkers.  By taking advantage of the 
unique thermal properties of PETG, this system serves as the first example of a supramolecular 
engineering polymer with enhanced thermal and mechanical properties that also shows improved 
melt viscosity at temperatures suitable for non-degradative processing.   
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CHAPTER 1: INTRODUCTION TO FUNCTIONAL POLYESTERS FOR 
BIOMEDICAL AND INDUSTRIAL APPLICATIONS 
 
 
1.1 Overview 
This dissertation describes the synthesis, characterization, and elucidation of the 
structure-property relationships of functionalized polyesters for biomedical and industrial 
applications.  Iodine functionalized polyesters were designed to achieve radiopaque biomaterials.  
Section 1.2 reviews important information pertaining to the development of radiopaque 
biopolymers for use as computed tomography nanoparticle contrast agents and inherently 
radiopaque, smart biomaterials.  Section 1.3 provides background information explaining the 
promising field of functionalized engineering polyesters.  In this thesis, endgroup 
functionalization of low molecular weight engineering polyesters was implemented in the 
development of robust plastics that have low melt viscosities.   
1.2 Introduction to Radiopaque Biomaterials 
1.2.1 Computed Tomography 
Computed tomography (CT) is one of the most widely applied imaging technologies in 
diagnostic medicine.   Sir Godfrey Hounsfield, a British engineer, invented the first CT scanner. 
Hounsfield went on to receive the 1979 Nobel Prize in Medicine, only seven years after the first 
clinical trial.1  Today, CT is broadly accessible and cost efficient, with more than 85 million CT 
procedures performed annually in the United States.2 
CT relies on x-ray penetration and attenuation to generate images.  An x-ray tube is 
rotated around the patient, generating thin cross-sectional images at each angle.  These thin slices 
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are then reconstructed to determine the attenuation in each voxel, where attenuation is defined as 
the decrease in intensity of transmitted x-rays due to absorption or scattering: 
I = I0-µx …………………………. (equation 1.1). 
I is the intensity of the transmitted x-rays, I0 is the intensity of the incident x-rays, µ is the mass 
attenuation coefficient of the object, and x is the thickness of the object being imaged.3,4  It is 
important to note that µ is proportional to the third power of the atomic number (Z) of the imaged 
material,3,5  and the quality of the developed image is dependent on the electron densities of the 
object being imaged and the surrounding medium.   
The attenuation coefficient for each voxel can then be converted to its CT number, called 
a Hounsfield unit (HU):  
HU = K∙ (#$%&'(	*	#+,-'.)#+,-'. …………………… (equation 1.2). 
K is an integer constant, typically 1000.  For example, the attenuation number of water is 0 HU.  
Air (µair ≈ 0) results in a CT number of approximately -1000 HU, and dense bone (µ ≈ 2µwater) is 
approximately +1000 HU.1  Soft tissues have densities similar to water (typically between 40-80 
HU) and are hard to distinguish by CT; whereas, the density of bone compared to its surrounding 
muscle tissue is easy to visualize.5 
Three-dimensional (3D) images are obtained with high spatial resolution from 
reconstructed image slices using CT.  Anatomic details are interpreted using these 3D CT images 
for diagnosing diseases and deciphering treatment options.3  Furthermore, CT has high temporal 
resolution (<50 ms for a complete scan), making CT preferable for tasks such as cardiac motion 
imaging.1  Oftentimes, contrast agents, which contain atoms of high Z, are used to enhance the 
visibility of soft tissue areas.  According to the 2012 IMV Medical Information Division CT 
survey, of the 85.3 million CT procedures performed in the U.S. in 2011, over half (53%) 
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utilized contrast agents, amounting to over eight million liters of traditional contrast media 
consumed each year.2,6 
1.2.2 Computed Tomography Contrast Agents 
1.2.2.a Traditional Contrast Agents 
Clinically used contrast agents are small molecules derived from 1,3,5-triiodobenzene 
(Figure 1.1).3,4,6–8  These compounds are utilized due to the high Z of iodine.  To increase the 
biocompatibility of the aromatic base structure, functional groups such as alcohols and amides 
were added.3,6  Although several small molecule contrast agents exist,  the pharmacokinetics and 
potential negative effects are similar for all categories.6 
 
 
Figure 1.1 Chemical structures of well-known iodinated contrast agents: iopromide 
(ULTRAVIST®), iohexol (OMNIPAQUE®), and the dimer, iodixanol (VISIPAQUE®).3,4,6–8 
	
The most common and serious side effect of traditional, intravascular CT contrast agents 
is contrast medium-induced nephrotoxicity (CIN), which is one of the most common causes of 
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hospital-acquired kidney failure.9  Risk factors for nephrotoxicity from CT contrast agents 
include existing poor renal function (particularly seen in elderly patients), diabetes, kidney 
disease, and chemotherapy use.10,11  In a study by Rudnick et al., patients with preexisting renal 
insufficiency demonstrated a 21.2 times greater risk for nephrotoxicity than patients without 
renal insufficiencies.8  Moreover, clinical studies of CIN in “high risk” patients include strict 
enrollment criteria.  In many studies, patients with compromised renal function due to disease or 
illness (i.e., diabetes or cancer) were not eligible.  These studies also ensured that patients were 
optimally hydrated; therefore, real-life clinical incidences of CIN may be even greater.8  
Difficulties, such as CIN, have reduced the utility of CT and its medical diagnostic capabilities.  
The development of novel contrast agents that are safe and effective for patients with renal 
dysfunction is critical. 
Additional limitations of traditional contrast agents include vascular permeation and non-
specific biodistribution, which limits microvascular and targeting performance.12,13  Also, the 
rapid excretion (blood half-life of <10 minutes) of small molecule contrast agents restricts 
imaging times.12  The utilization of nanotechnology could allow increased circulation times, 
targeted imaging, and avoidance of the kidneys by size exclusion. 
1.2.2.b Metal-based Nanoparticles as Contrast Agents 
Metal-based materials, such as tantalum, gold, and bismuth have high atomic numbers (Z 
= 73, 79, 83, respectively), and thus high x-ray attenuation capabilities.  Therefore, metal-based 
nanoparticles have been extensively studied for use as improved CT contrast agents.3,14–23   
Gold nanoparticles (AuNPs) are the most broadly studied metallic nanoparticles.24  
Although bare AuNPs showed detailed anatomical images, these nanoparticles were excreted 
through the kidneys due to their small size (1.9 nm) and easily aggregated in vivo.25  Therefore, 
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AuNPs were synthesized via the Turkevich method, which utilizes the reduction of HAuCl4 with 
citrate in aqueous conditions.12,25  Citrate-stabilized AuNPs are readily modified with surface 
coatings, such as SH-PEG or the mussel-inspired adhesive, 3,4-dihydroxyphenylalanie 
(DOPA).12,15,26  PEG functionalized AuNPs were biocompatible (noncytotoxic), accumulated in 
phagocyte-rich organs, such as the liver and spleen, and displayed long circulation times.12  
Figure 1.2 displays PEG functionalized AuNPs injected via tail-vein into a rat.  The 
nanoparticles allowed visualization of the liver and clearly revealed a hepatoma.12 
 
 
Figure 1.2 This figure was adapted and used from reference 12.  CT images in a rat hepatoma 
model following injection PEG-coated AuNPs:  a) before injection, b) 5 minute-mark (directly 
after injection of the AuNPs), c) 1 hour, d) 2 hours, e) 4 hours, and f) 12 hours after injection. 
Large arrows indicate the hepatoma regions. The numbers shown in brackets in the upper right-
hand corner of the images indicate the HU values of the hepatoma regions (left) and the 
surrounding normal liver parenchyma (right).12 
 
 
Although AuNPs have been studied extensively and show great promise, they are too 
expensive for sustainable translation to a hospital setting.6,25  Research utilizing bismuth and 
tantalum hopes to address the impending costs of gold-based contrast agents.  Elemental bismuth 
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is inherently toxic, and Bi2S3 nanocrystals show a safety profile similar to traditional iodinated 
contrast agents.25  Therefore, Bi2S3 nanoparticles coated with polyvinylpyrrolidone, PEG, or 
phospholipids were developed.13,22,27  Polymer-coated Bi2S3 nanoparticles showed higher x-ray 
absorption than iodinated contrast agents, but their size, shape, and stability remained a 
challenge.12,15,28  In one example by Sailor and coworkers, Bi2S3 nanoparticles were coated using 
DSPE-PEG via noncovalent bonding and labeled using the LyP-1 peptide (used to target 4T1 
breast cancer tumors) to produce 28 nm particles.28  The particles provided sufficient contrast for 
detailed CT images of targeted tumors, and they were mainly cleared by the liver and spleen.  
Approximately 4% of the nanoparticles were cleared by the kidneys, and a small amount of 
agglomeration occurred (evident in the lungs), suggesting degradation into ionic bismuth in 
vivo.28 
Tantalum and tantalum oxide are widely used in clinical applications as radiographic 
markers and implants.19  Tantalum oxide  nanoparticles have been synthesized with various 
silane-modified surfaces that allow easy immobilization of a PEG corona.18–20  These particles 
show improvements over traditional contrast agents, such as long circulation times and the 
potential for multimodal imaging.19,20  In the work of Hyeon and coworkers, a fluorescent dye 
was introduced to PEG functionalized tantalum oxide nanoparticles, allowing bimodal 
visualization of the lymph nodes using CT and fluorescence imaging (Figure 1.3).19  Due to the 
small size of tantalum-based nanoparticles (5-19 nm), excretion through the kidneys remains a 
concern.5,18   
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Figure 1.3 This figure was adapted from reference 19.  Schematic of tantalum oxide 
nanoparticles functionalized with PEG and a fluorescent marker (RITC-APTES) (left).  TEM 
images (right) showing size control and small size of the nanoparticles.19 
 
1.2.2.c Iodinated Nano-carriers and Nanoparticles 
Iodine-based nano-carriers, such as nano-emulsions, micelles, and liposomes, were 
developed to circumvent the limitations of traditional, small molecule contrast media.13,29–32  
Polymeric micelles can have CMCs up to 1000-fold lower than those of surfactant-based nano-
emulsions and micelles.33   De Vries et al. formulated emulsions using radiopaque oils derived 
from the 2,3,5-triiodobenzoate moiety.  Emulsions using either phospholipids or amphiphilic 
polymers were tested in vivo as CT blood pool contrast agents.  The phospholipid-based 
emulsion was unstable and caused acute lung embolism and mouse death, presumably as a result 
of low colloidal stability.  Conversely, the polymer-stabilized emulsion showed a long blood 
circulation half-life (3 hours), exhibited no noticeable signs of toxicity, and was metabolized by 
the liver.29   
PEG-RITC-TaOx
PEG-silane
RITC-APTES
TaOx
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In another example, liposome-encapsulated iodixanol (a traditional contrast agent, Figure 
1.1) was tested in a clinical trial.  While x-ray attenuation was significantly enhanced, side 
effects such as backache, chills, and flu-like symptoms were considered too pronounced for 
clinical use.30  A similar liposomal system encapsulating iopromide (Figure 1.1) also showed 
enhanced attenuation (>60 HU from baseline).  However, when testing the mean lethal dose of 
this liposomal system against free iopromide, the free agent was better tolerated.31  Poor stability 
of micellar and liposomal systems, including aggregation and leakage of encapsulated agents, 
remains a concern.32,33   
To circumvent the stability issues of nano-carriers, polymeric core-shell nanoparticles 
and new polymer systems were researched.34–37  As depicted in Figure 1.4, Kong et al. 
synthesized nano-capsules of crosslinked poly(ethylene glycol)-poly(propylene glycol)-
poly(ethylene glycol) (Pluronic) encasing Lipiodol®, an iodinated derivative of poppy seed oil.37  
These 150 nm core-shell particles were stable and noncytotoxic.  Furthermore, the particles 
enhanced attenuation for 4 hours and accumulated in the liver and spleen.  After histological 
analysis, however, slight aggregation due to protein adsorption was observed.37 
 
 
Figure 1.4 Figure taken from reference 37.  Synthetic scheme for core-shell nanoparticles made 
by Kong et al.37 
NPC activated F127
Oil-in-water emulsion
PEG Organic solvent with Lipiodol Lipiodol Core
Pluronic/PEG 
Nanocapsules
Containing Lipiodol
Solvent 
evaporation
PEG-amine2
Crosslinking
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New polymer systems utilized aromatic ring-bound iodine in methacrylates,38,39 
styrenics,40 anhydride esters,41 and cellulose.42  For example, the emulsion polymerization of 2-
methacryloyloxyethyl(2,3,5-triiodobenzoate) formed nanoparticles of approximately 25.5 nm.  
These nanoparticles showed elevated visibility of the blood pool for 30 minutes after injection 
and were removed by the mononuclear phagocyte system.34   
All of the contrast agents described to this point utilized metals or aromatic ring-bound 
iodine.  While aromatic ring-bound iodine is likely employed to increase the stability of the 
covalently bound iodine, the precursors are expensive, toxic, and poorly biodegradable.  An ideal 
contrast agent should be radiopaque, cost-effective, biocompatible, long-circulating, safely 
excreted, and easily formulated.    
1.2.3 Radiopaque Polymers 
1.2.3.a Polymer Mixtures 
 Typical organic polymer biomaterials are radiolucent due to their lack of high Z 
elements.  In many cases, however, radiopacity is necessary for monitoring implantation; for 
example, radiolucent stents run the risk of improper placement.43,44  For this reason, many 
polymeric implants include metallic markers made of platinum, gold, or titanium.43,45–47   
Heterogeneous polymer mixtures utilizing inorganic salts or metallic particles were also 
developed to induce radiopacity.48–53  For example, bone cements are typically made from 
PMMA composites comprising barium sulfate, zirconium dioxide, or tantalum oxide.48,54–58  
Drawbacks of heterogeneous polymer mixtures include incompatibility with the polymer matrix 
(e.g., negative effects on physical, thermal, or mechanical properties) and leaching of the 
radiopaque additives.   Leaching can result in the loss of radiopacity of the implant, additive 
aggregation (aggregates can obstruct implantation pathways, such as the small lumen of a 
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catheter), or toxicity.44,59  Inorganic radiopaque agents and radiocontrast-inducing additives can 
also cause undesirable discoloration, which limits the pigment options of the material in its final 
form.60 
 Homogeneous mixtures were made by chelating heavy metal salts with  polymers.53,61,62  
In an example by Smid and coworkers, organobismuth (e.g., Ph3Bi) was incorporated with 
PMMA, PVC, and polystyrene.  In all cases, the addition of only 1.3% by weight (b.w.) of the 
organobismuth additive plasticized the polymers and lowered the Tg; however, a minimum of 
24% b.w. of the additive was necessary to match the radiopacity of an aluminum control.62 
1.2.3.b Inherently Radiopaque Polymers 
 Inherently radiopaque polymers, utilizing covalently bound iodine, supersede many of the 
issues involved with heterogeneous and homogeneous polymer mixtures, such as inhomogeneity, 
leaching of additives, and thermomechanical property variations.  One approach to designing 
inherently radiopaque polymers involves post-functionalization of high molecular weight 
polymers with iodinated molecules.  Post-functionalization has been demonstrated on cellulose 
esters,42 polyurethanes,63 and poly(organophosphazenes).64  Allcock and coworkers post-
functionalized poly(dichlorophosphazene) to create 3,5-diiodotyrosine ethyl ester or 4-
iodophenylalanine ethyl ester side groups.64  In another example, James et al. functionalized a 
commercially available polyurethane (Tecoflex 80 A) with triiodobenzoyl chloride or N-(2,6-
diiodocarboxyphenyl)-3,4,5-triiodo benzamide (Figure 1.5) via urethane linkages on the polymer 
backbone.63 
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Figure 1.5 N-(2,6-diiodocarboxyphenyl)-3,4,5-triiodobenzamide was used to functionalize a 
radiolucent polyurethane.63 
	
 Another approach to making inherently radiopaque polymers involves the use of 
iodinated monomers in polymerization.  As briefly described in Section 1.2.2.c, several 
methacrylate-based iodinated polymers have been developed (Figure 1.6);38,65–70 additionally, 
radiopaque TPUs and polyesters were designed.50,59,63,71–73  All of these polymers incorporate 
aromatic iodinated monomers.  For example, many radiopaque TPUs utilize an iodinated 
Bisphenol-A (I-BPA).59,73  These I-BPA-based TPUs had various properties and degradation 
profiles; however, BPA is a controversial monomer that has been banned from certain 
applications by the FDA.74   
In a unique example by Rode et al., 2,2-bis(hydroxyl-methyl)propane-1,3-diyl-bis(2,3,5-
triiodobenzoate) was synthesized using 2,3,5-triiodobenzoic acid and 2,2-dimethyl-(1,3-dioxane-
5,5-diyl)dimethanol.  This molecule was then used to make polyesters and polyester urethanes by 
ring opening polymerization (Figure 1.7 depicts the polyester).  These polyesters and TPUs were 
hydrolytically biodegradable; however, the radiopacity of the polymers over the course of 
degradation was not analyzed.71   
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Figure 1.6 A variety of iodinated monomers developed for radiopaque methacrylate-based 
polymerizations:  A) triiodophenyl methacrylate,65 B) 2-methacryloyloxyethyl(2,3,5-
triiodobenzoate),38,66,67 C) 3-(methacryloylamidoacetamido)-2,4,6-triiodobenzoic acid,68 D) 2-
(2’-iodobenzoyl)-ethyl methacrylate,69 E) 2-(4’-iodobenzoyloxy)-ethylmethacrylate.70 
 
 
Figure 1.7 Iodine-containing polyesters made via ring opening polymerization.71 
 
Only two examples utilizing nonaromatic iodine (iodine that is not attached to aryl 
moieties) were found in the literature.  One of these aliphatic polymers was designed primarily 
for flame retardant purposes and contained a significant amount of the brominated precursor.75  
The other example involved the synthesis of a-iodo-e-caprolactone to make iodinated 
poly(caprolactone) (PCL); post-functionalization of PCL to make poly(a-iodo-e-caprolactone) 
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was also implemented.76–78  The secondary iodine in poly(a-iodo-e-caprolactone) presumably 
allows side-reactions, such as SN1, SN2, E1 and E2.   
1.2.4 Radiopaque Shape Memory Biomaterials 
1.2.4.a The Shape Memory Cycle 
Shape memory polymers are a class of smart materials that can be programmed into a 
permanent and a temporary shape.  These polymers are typically elastomers; therefore, the 
permanent shape is programmed by chemical crosslinks, referred to as permanent netpoints.  The 
temporary shape is programmed by the application of a stimulus, such as heat or light, and a 
force.  In the case of thermal shape memory, semicrystalline polymers are often utilized.  
Crystallites provide physical netpoints that preserve the temporary shape after the force is 
removed and until the material is recovered by exposing the material to the stimulus, heat.  Once 
the material, in its temporary shape, is heated above its Tm, it will return to its entropically 
preferred permanent shape, which was encoded by chemical crosslinks.79–81  Figure 1.8 depicts 
the shape memory cycle. 
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Figure 1.8 The Shape Memory Cycle:  The sample is first cured into its permanent shape.  1.  
The sample is heated to melt all crystallites.  2. The sample is deformed, in this case extended, 
using a force.  3. While under this force, the sample is cooled to produce crystallites that secure 
the temporary shape.  4. The force is released.  5. Upon heating above the Tm, the crystallites 
melt, and the sample returns to the permanent shape. 
 
 The effectiveness of the material to perform shape memory is quantified by strain fixity 
(Rf) and strain recovery (Rr), as shown in equations 1.3 and 1.4.  Fixity refers the sample’s 
ability to maintain its temporary shape after the force is released, and recovery quantifies the 
sample’s ability to transition back to the permanent shape upon reheating.  In equations 1.3 and 
1.4, eu represents strain after unloading the force, εm represents temporal strain after deformation, 
and εp represents the permanent strain after heat induced recovery.81  
 
 𝑅1	 % = 	 4546 	 ∙ 100…………………………… (equation 1.3) 
 𝑅9	 % = 	 (45*4:)(46*4:) 	 ∙ 100………………………… (equation 1.4) 
 
1. T > Tm
2. Extend
3. Cool
4. Release force
5. T > Tm
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1.2.4.b Traditional Shape Memory Biomaterials 
Shape memory polymers have shown particular value as biomaterials; further, many 
biocompatible polymers have innate shape memory properties.  Shape memory polymers include 
PCL,82,83 poly(lactic acid),84 polyurethanes,85–87 polyethylene,88,89 and variations of poly(octylene 
adipate).90–92  Biomedical applications of shape memory polymers include self-tying sutures,82 
deployable stents,93,94 and mechanically active scaffolds.52,95  Thus, shape memory biomaterials 
can significantly lower the invasiveness of implantation.82  Figure 1.9A displays a self-tying 
suture made using oligo(ε-caprolactone)diol and oligo(p-dioxanone)diol copolymers developed 
by Lendlein and Langer.82  In Figure 1.9A, the copolymer self-ties over a period of 20 seconds at 
T > Tm.  In Figure 1.9B, Gall and coworkers developed a deployable stent using crosslinked 
networks of tert-butyl acrylate, di(ethylene glycol) dimethacrylate, and poly(ethylene glycol) 
dimethacrylate.93  
 
 
Figure 1.9 Shape memory biomaterials adapted from references 83 and 94:  A) self-tying 
suture,82 and B) deployable stent.93 
 
 
A) B)
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1.2.4.c Radiopaque Shape Memory Polymers 
Shape memory polymers have shown great utility in the biomedical field, where 
radiopacity is of specific interest.  The first examples of materials with x-ray and shape memory 
properties were radiopaque shape memory alloys.  Shape memory alloys are provided 
radiocontrast through fabrication with expensive elements, such as platinum or erbium;96–98 
therefore, the addition of radiopacity to shape memory polymers would be beneficial for cost and 
environmental reasons.99  Although none of the polymers depicted in Section 1.2.3.b were tested 
for “smart” capabilities, such as shape memory, inherently radiopaque polymers in the form of 
TPUs and semicrystalline polyesters (e.g., PCL) should be capable of performing shape memory. 
 To date, all of the polymers specifically tested for shape memory were provided 
radiocontrast through impregnation using inorganic salts and particles or contrast   
agents.52,95,100–102  In an example by Wong et al., PLGA/PEG copolymers showed shape memory 
properties and were provided radiopacity using filament compounds based on barium, bismuth, 
and tantalum (Figure 1.10).100  In this example, the shape memory effect was triggered by water 
by taking advantage of the solubility of PEG.  This radiopaque shape memory device was tested 
in vivo in a rabbit model as an embolization plug for temporary vascular occlusion.  Other 
examples of radiopaque shape memory composites involve BaSO4 impregnation of polyether 
urethanes for active tissue engineering scaffolds.52,95  These examples are heterogeneous polymer 
mixtures, and therefore, possess the potential disadvantages outlined in Section 1.1.3.a. 
 An ideal radiopaque shape memory polymer should be provided radiopacity through 
covalently bound, stable iodine.  The iodinated precursors and subsequent polymers should be 
nontoxic, biocompatible, and biodegradable.  Additionally, in the case of thermal shape memory, 
the polymer should have a Tm slightly above body temperature and have long-lasting radiopacity. 
	 17 
 
 
Figure 1.10 Radiopaque shape memory device from figures adapted from reference 101.  A) 
Schematic of the shape memory polymer.  This shape memory system consists of a PLGA 
composite core coated with a crosslinked PEG hydrogel.  Recovery of the initial shape was 
achieved when the hydrogel swelled in the presence of water, the stimulus.  B)  X-ray image of a 
radiopaque shape memory embolic plug prototype (red arrow) using a micro-catheter (yellow 
arrow) in a rabbit model.  As the hydrogel swelled, vascular embolization was achieved (left to 
right).100 
	
1.2.5. Summary 
The development of new, radiopaque materials could augment procedures performed in 
the biomedical and radiology fields.  In this dissertation, radiopaque polyesters were synthesized 
using a unique, aliphatic, iodinated monomer.  These polymers were fabricated into 
nanoparticles as improved CT contrast agents (Chapter 2) and thermosets as inherently 
radiopaque shape memory materials (Chapter 3).  The work outlined in Chapter 2 has been 
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submitted for publication, and the work outlined in Chapter 3 is currently in preparation for 
submission. 
1.3 Supramolecular Engineering Polyesters 
1.3.1 Supramolecular Chemistry via Ureidopyrimidinone Endgroup Functionalization 
Supramolecular chemistry takes place due to non-covalent bonds, such as pi-pi 
stacking,103 ionomers,104,105 metal-ligand,106–108 and host-guest complexes.109  Materials 
incorporating hydrogen bonding moieties are the most well-studied of the supramolecular 
polymer families.  These supramolecular interactions have been displayed in the form of weak 
H-bonding (e.g., -COOH)110 or in the form of multiple H-bonding (e.g., DNA).111  Multiple 
hydrogen bonds via the quadruple H-bonding ureidopyrimidinone (UPy) group (Figure 1.11) are 
known to produce superior, thermally reversible supramolecular assemblies that dramatically 
alter the properties of the initial molecule or polymer.112–116   
 
 
Figure 1.11 The quadruple hydrogen bonding dimerization of the ureidopyrimidinone (UPy) 
moiety.  R can represent attachment to a small molecule, direct attachment to a polymer, or 
attachment to a linker unit, which attaches the UPy unit to a polymer. 
 
Although H-bonds are directionally selective, the UPy group is self-complimentary; thus, 
stoichiometry does not affect the degree of supramolecular polymerization.112  Therefore, the 
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supramolecularly enhanced molecular weight of UPy functionalized polymers leads to increased 
mechanical properties, like elasticity (Figure 1.12).114,115  This enhancement, in part, is due to the 
strength of the H-bonds in a UPy dimer, which falls between that of a single H-bond (5-65 kJ 
mol-1) and a covalent bond (350 kJ mol-1).104,117  Nevertheless, the quadruple H-bonds shown in 
Figure 1.11 while strong, are also dynamic.  Thus, low melt viscosities can be achieved as a 
result of the thermal reversibility of UPy-UPy aggregation.114,115  The combination of apparently 
orthogonal properties via UPy functionalization is beneficial in the application of self-
healing,118,119 recyclable,120 and adhesive materials.121 
 
 
Figure 1.12 Figure taken from reference 114.  Poly(ethylene butylene) with hydroxyl endgroups 
(left) compared to poly(ethylene butylene) with UPy endgroups (right).114 
 
 
Polymer functionalization using the UPy group is extremely versatile.  UPy groups can 
be attached to polymers using a variety of synthetic techniques.  The most common approach 
utilizes isocyanate-functionalized isocytasines with a choice of several nucleophiles at the 
polymer termini (e.g., hydroxyl or amine).114,115,122,123  Modification of the R group (Figure 1.11) 
can alter the strength and extent of UPy aggregation and polymerization.  For example, 
modifying the type of linker attaching the UPy unit to the polymer termini can allow lateral 
stacking in addition to the dimerization depicted in Figure 1.11.115,124  Kautz et al. functionalized 
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the termini of poly(ethylene butylene) (PEB) with a variety of endgroups (Figure 1.13).115  Direct 
functionalization of PEB with the UPy moiety did not lead to fiber formation or an apparent Tm 
(Figure 1.13a).  When the UPy group was attached to PEB via a hexamethylene with two urea 
groups (Figure 1.13d), micrometer long fibers formed as well as a clear Tm at 129 °C.  PEB with 
linear bisurea-functionalized termini showed aggregation in the form of small fibers (Figure 
1.13b), thus providing evidence that the linker attaching the UPy end-unit to the polymer plays a 
major role in fiber formation and UPy-UPy “crystallization”.115  A study by Appel et al. 
indicated that the driving force of fiber formation is phase separation of the endgroup clusters 
from the polymer backbone, and this phase separation was only achievable with oligomers of 
low Tg (PEB has a Tg of -57 °C and no inherent Tm).124 
 
 
Figure 1.13 Figure adapted from reference 115:  TEM images of thin films made from PEB 
functionalized with various endgroups at both termini.  Chemical structure of the endgroups are 
depicted next to each TEM image.115 
 
 The vast majority of supramolecular polymers are low performing, such as PEO/PPO,112 
PDMS,123 PEB,113–115 polyTHF,116,122 PCL,122,125,126 and aliphatic polycarbonates.116,127  
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Hydrogen bonding moieties were also applied to polymers with higher glass transition 
temperatures, such as polystyrene.128–131  For example, Rotello and coworkers presented styrenic 
polymers with triple H-bonding moieties.128–130  However, the UPy moiety has had limited 
investigation with more robust glassy or semi-crystalline polymers.   
Long and coworkers attached the UPy moiety to polystyrene and poly(butylene 
terephthalate).131,132  In one case, polystyrene, polyisoprene and poly(styrene-b-isoprene) were 
UPy functionalized.  All of the materials were analyzed by DSC, TGA, and GPC.  Notably, the 
degradation temperature of the polymers decreased and the Tg increased as a result of UPy 
functionalization.  Only functionalized polyisoprene and poly(styrene-b-isoprene) were studied 
further using rheology and TEM.131   
1.3.2 Engineering Polyesters 
The development of high molecular weight, semi-aromatic polyesters, specifically 
poly(ethylene terephthalate) (PET), was first reported the late 1940s by Whinfield and 
Dickson.134  Since these early developments, engineering polyesters have become some of the 
most important and ubiquitous polymers for a number of applications.  Engineering polyesters 
are used for computers, televisions, kitchen appliances, agriculture equipment, medical devices, 
and packaging (e.g., medical, food, specialty).  For example, PET is the foremost engineering 
polyester used in the production of synthetic fibers for applications like tire reinforcement and 
clothing, with more than 17,000 kilotons produced each year.135  As polymer science advanced, 
the demands of industrial manufacturers and consumers raised; therefore, a variety of other semi-
aromatic and aromatic engineering polyesters and copolyesters were designed. 
 In the late 1950s, Eastman Kodak patented poly(1,4-cyclohexylenedimethylene 
terephthalate) (PCT) and cis/trans-1,4-cyclohexanedimethanol (CHDM) modified variations of 
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PET (Figure 1.14).136,137  During processing, polymers with high melting temperatures, like PCT 
(Tm ~ 290 °C), can thermally and hydrolytically degrade.  Although injection molding crystalline 
plastics is advantageous for some end-use applications (e.g., glass fiber reinforced formulations), 
lowering (or eliminating) the Tm is desired to decrease processing and crystallization 
temperatures.135  
 
 
Figure 1.14 A) PCT, B) PETG (m = major component) or PCTG (n = major component), C) 
PCTA when m £50 mol%.135–137   
 
CHDM-based copolymers (e.g., PETG, PCTG, and PCTA in Figure 1.14) were designed 
for the manufacture of more aesthetic injection molded or blow molded objects by modifying the 
comonomer make-up to suit the desired end-use.  The increased amorphous character of CHDM 
copolymers revealed improved clarity, impact strength, and dye uptake.135  For example, PETG 
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is the most widely used of the CHDM-based polyesters found in Figure 1.14.  PETG has no Tm 
by DSC and remains amorphous after processing; as a result, PETG is used for specialty 
packaging (e.g., cosmetics) where high clarity and impact toughness are important.135,138 
1.3.3 Summary 
The next step in the advancement of supramolecular chemistry should involve terminal 
UPy functionalization and thorough characterization of engineering and high performance 
oligomers.  Thorough examination of supramolecular engineering polymers would potentially 
open a new field of supramolecular chemistry.  This work would deepen the current 
understanding of supramolecular systems.133  In Chapter 4 of this dissertation, the synthesis and 
characterization of UPy functionalized PETG oligomers is summarized.  UPy functionalized 
PETG serves as the first example of a supramolecular engineering polymer with enhanced 
thermal, mechanical, and viscoelastic properties at pertinent use and processing temperatures.  
The work reviewed in Chapter 4 was published in RSC Polymer Chemistry (DOI: 
10.1039/c6py01421f).133 
 
  
	 24 
REFERENCES 
(1)  Goldman, L. W. J. Nucl. Med. Technol. 2007, 35, 115. 
(2)  IMV 2013 CT Market Outlook Report; 2013. 
(3)  Lee, N.; Choi, S. H.; Hyeon, T. Adv. Mater. 2013, 25, 2641. 
(4)  Yu, S. B.; Watson, A. D. Chem. Rev. 1999, 99, 2353. 
(5)  Shilo, M.; Reuveni, T.; Motiei, M.; Popovtzer, R. Nanomedicine 2012, 7, 257. 
(6)  Katzberg, R. W.; Haller, C. Kidney Int. 2006, 69, S3. 
(7)  Chalmers, N.; Jackson, R. W. 1999, 72, 701. 
(8)  Rudnick, M. R.; Goldfarb, S.; Wexler, L.; Ludbrook, P. A.; Murphy, M. J.; Halpern, E. F.; 
Hill, J. A.; Winniford, M.; Cohen, M. B.; Vanfossen, D. B. Kidney Int. 1995, 47, 254. 
(9)  Heinrich, M. C.; Haberle, L.; Muller, V.; Bautx, W.; Uder, M. Radiology 2009, 250, 68. 
(10)  Wang, A. Z.; Langer, R.; Farokhzad, O. C. Annu. Rev. Med. 2012, 63, 185. 
(11)  Corsonello, A.; Pedone, C.; Corica, F.; Mussi, C.; Carbonin, P.; Antonelli Incalzi, R. Arch. 
Intern. Med. 2005, 165, 790. 
(12)  Kim, D.; Park, S.; Lee, J. H.; Jeong, Y. Y.; Jon, S. J. Am. Chem. Soc. 2007, 129, 7661. 
(13)  Hyafil, F.; Cornily, J.-C.; Feig, J. E.; Gordon, R.; Vucic, E.; Amirbekian, V.; Fisher, E. A.; 
Fuster, V.; Feldman, L. J.; Fayad, Z. A. Nat. Med. 2007, 13, 636. 
(14)  Sun, I.-C.; Eun, D.-K.; Koo, H.; Ko, C.-Y.; Kim, H.-S.; Yi, D. K.; Choi, K.; Kwon, I. C.; 
Kim, K.; Ahn, C.-H. Angew. Chemie 2011, 50, 9348. 
(15)  Sun, I.-C.; Eun, D.-K.; Na, J. H.; Lee, S.; Kim, I.-J.; Youn, I.-C.; Ko, C.-Y.; Kim, H.-S.; 
Lim, D.; Choi, K.; Messersmith, P. B.; Park, T. G.; Kim, S. Y.; Kwon, I. C.; Kim, K.; 
Ahn, C.-H. Chemistry 2009, 15, 13341. 
(16)  Sharma, P.; Singh, A.; Brown, S. C.; Bengtsson, N.; Walter, G. A.; Grobmyer, S. R.; 
Iwakuma, N.; Santra, S.; Scott, E. W.; Moudgil, B. M. In Cancer Nanotechnology: 
Methods in Molecular Biology; Grobmyer, S. R., Moudgil, B. M., Eds.; Springer 
International Publishing, 2010; pp 67–81. 
(17)  Eck, W.; Nicholson, A. I.; Zentgraf, H.; Semmler, W.; Bartling, S. Nano Lett. 2010, 10, 
2318. 
(18)  Bonitatibus, P. J.; Torres, A. S.; Kandapallil, B.; Lee, B. D.; Goddard, G. D.; Colborn, R. 
E.; Marino, M. E. ACS Nano 2012, 6, 6650. 
	 25 
(19)  Oh, M. H.; Lee, N.; Kim, H.; Park, S. P.; Piao, Y.; Lee, J.; Jun, S. W.; Moon, W. K.; Choi, 
S. H.; Hyeon, T. J. Am. Chem. Soc. 2011, 133, 5508. 
(20)  Xiao, Q.; Bu, W.; Ren, Q.; Zhang, S.; Xing, H.; Chen, F.; Li, M.; Zheng, X.; Hua, Y.; 
Zhou, L.; Peng, W.; Qu, H.; Wang, Z.; Zhao, K.; Shi, J. Biomaterials 2012, 33, 7530. 
(21)  Fang, Y.; Peng, C.; Guo, R.; Zheng, L.; Qin, J.; Zhou, B.; Shen, M.; Lu, X.; Zhang, G.; 
Shi, X. Analyst 2013, 138, 3172. 
(22)  Kinsella, J. M.; Jimenez, R. E.; Karmali, P. P.; Rush, A. M.; Kotamraju, V. R.; 
Gianneschi, N. C.; Ruoslahti, E.; Stupack, D.; Sailor, M. J. Angew. Chemie 2011, 50, 
12308. 
(23)  Rabin, O.; Manuel Perez, J.; Grimm, J.; Wojtkiewicz, G.; Weissleder, R. Nat. Mater. 
2006, 5, 118. 
(24)  Anselmo, A. C.; Mitragotri, S. AAPS J. 2015, 17, 1041. 
(25)  He, W.; Ai, K.; Lu, L. Sci. China Chem. 2015, 58, 753. 
(26)  Dalsin, J. L.; Hu, B.-H.; Lee, B. P.; Messersmith, P. B. J. Am. Chem. Soc. 2003, 125, 
4253. 
(27)  Pan, D.; Roessl, E.; Schlomka, J. P.; Caruthers, S. D.; Senpan, A.; Scott, M. J.; Allen, J. 
S.; Zhang, H.; Hu, G.; Gaffney, P. J.; Choi, E. T.; Rasche, V.; Wickline, S. A.; Proksa, R.; 
Lanza, G. M. Angew. Chemie 2010, 49, 9635. 
(28)  Kinsella, J. M.; Jimenez, R. E.; Karmali, P. P.; Rush, A. M.; Kotamraju, V. R.; 
Gianneschi, N. C.; Ruoslahti, E.; Stupack, D.; Sailor, M. J. Angew. Chemie 2011, 50, 
12308. 
(29)  de Vries, A.; Custers, E.; Lub, J.; van den Bosch, S.; Nicolay, K.; Grüll, H. Biomaterials 
2010, 31, 6537. 
(30)  Leander, P.; Höglund, P.; Børseth, A.; Kloster, Y.; Berg, A. Eur. Radiol. 2001, 11, 698. 
(31)  Leike, J. U.; Sachse, A.; Rupp, K. Invest. Radiol. 2001, 36, 303. 
(32)  Montet, X.; Pastor, C. M.; Vallée, J.-P.; Becker, C. D.; Geissbuhler, A.; Morel, D. R.; 
Meda, P. Invest. Radiol. 2007, 42, 652. 
(33)  Hallouard, F.; Anton, N.; Choquet, P.; Constantinesco, A.; Vandamme, T. Biomaterials 
2010, 31, 6249. 
(34)  Aviv, H.; Bartling, S.; Kieslling, F.; Margel, S. Biomaterials 2009, 30, 5610. 
(35)  Bae, K. H.; Lee, Y.; Park, T. G. Biomacromolecules 2007, 8, 650. 
(36)  Hallouard, F.; Briançon, S.; Anton, N.; Li, X.; Vandamme, T.; Fessi, H. Pharm. Res. 
	 26 
2013, 30, 2023. 
(37)  Kong, W. H.; Lee, W. J.; Cui, Z. Y.; Bae, K. H.; Park, T. G.; Kim, J. H.; Park, K.; Seo, S. 
W. Biomaterials 2007, 28, 5555. 
(38)  Galperin, A.; Margel, S. Biomacromolecules 2006, 7, 2650. 
(39)  Galperin, A.; Margel, D.; Baniel, J.; Dank, G.; Biton, H.; Margel, S. Biomaterials 2007, 
28, 4461. 
(40)  Galperin, A.; Margel, D.; Margel, S. J. Biomed. Mater. Res. Part A 2006, 79, 545. 
(41)  Carbone, A. L.; Song, M.; Uhrich, K. E. Biomacromolecules 2008, 9, 1604. 
(42)  Mottu, F.; Rüfenacht, D. A.; Laurent, A.; Doelker, E. Biomaterials 2002, 23, 121. 
(43)  Serruys, P. W.; Ormiston, J. A.; Onuma, Y.; Regar, E.; Gonzalo, N.; Garcia-Garcia, H. 
M.; Nieman, K.; Bruining, N.; Dorange, C.; Miquel-Hébert, K.; Veldhof, S.; Webster, M.; 
Thuesen, L.; Dudek, D. Lancet 2009, 373, 897. 
(44)  Agusti, G.; Jordan, O.; Andersen, G.; Doelker, E.; Chevalier, Y. J. Appl. Polym. Sci. 2014, 
132, 41791. 
(45)  Ormiston, J. A.; Serruys, P. W. S. Circ. Cardiovasc. Interv. 2009, 2, 255. 
(46)  Escorsell, A.; Bosch, J. Gastroenterol. Res. Pract. 2011, 2011, 1. 
(47)  Hubmann, R.; Bodlaj, G.; Czompo, M.; Benko, L.; Pichler, P.; Al-Kathib, S.; Kiblbock, 
P.; Shamyieh, A.; Biesenbach, G. Endoscopy 2006, 38, 896. 
(48)  Kurtz, S. M.; Villarraga, M. L.; Zhao, K.; Edidin, A. A. Biomaterials 2005, 26, 3699. 
(49)  Constant, M. J.; Keeley, E. M.; Cruise, G. M. J. Biomed. Mater. Res. B. Appl. Biomater. 
2009, 89, 306. 
(50)  Kiran, S.; James, N. R.; Jayakrishnan, A.; Joseph, R. J. Biomed. Mater. Res. Part A 2012, 
100, 3472. 
(51)  Kim, H.-C.; Chung, Y. S. Fibers Polym. 2013, 14, 292. 
(52)  Cui, J.; Kratz, K.; Heuchel, M.; Hiebl, B.; Lendlein, A. Polym. Adv. Technol. 2011, 22, 
180. 
(53)  Rawls, H. R.; Starr, J.; Kasten, F. H.; Murray, M.; Smid, J.; Cabasso, I. Dent. Mater. 
1990, 6, 250. 
(54)  Moszner, N.; Salz, U. Prog. Polym. Sci. 2001, 26, 535. 
(55)  Boelen, E. J. H.; Lewis, G.; Xu, J.; Slots, T.; Koole, L. H.; Van Hooy-Corstjens, C. S. J. J. 
	 27 
Biomed. Mater. Res. Part A 2008, 86, 76. 
(56)  Heini, P.; Berlemann, U. Eur. Spine J. 2001, 10, 205. 
(57)  Vázquez, B.; Ginebra, M. P.; Gil, F. J.; Planell, J. A.; López Bravo, A.; San Román, J. 
Biomaterials 1999, 20, 2047. 
(58)  Mitchell, W.; Matthewsa, J. B.; Stone, M. H.; Fisher, J.; Ingham, E. Biomaterials 2003, 
24, 737. 
(59)  Kiran, S.; James, N. R.; Joseph, R.; Jayakrishnan, A. Biomaterials 2009, 30, 5552. 
(60)  Carbone, A. L.; Song, M. J.; Uhrich, K. E. Biomacromolecules 2008, 9, 1604. 
(61)  Rawls, H. R.; Granier, R. J.; Smid, J.; Cabasso, I. J. Biomed. Mater. Res. 1996, 31, 339. 
(62)  Delaviz, Y.; Zhang, Z.-X.; Cabasso, I.; Smid, J. J. Appl. Polym. Sci. 1990, 40, 835. 
(63)  James, N. R.; Philip, J.; Jayakrishnan, A. Biomaterials 2006, 27, 160. 
(64)  Hindenlang, M. D.; Soudakov, A. A.; Imler, G. H.; Laurencin, C. T.; Nair, L. S.; Allcock, 
H. R. Polym. Chem. 2010, 1, 1467. 
(65)  Davy, K. W. M.; Anseau, M. R.; Odlyha, M.; Foster, G. M. Polym. Int. 1997, 43, 143. 
(66)  Saralidze, K. S.; Aldenhoff, B. J.; Knetsch, L. W.; Koole, L. H. Biomacromolecules 2003, 
4, 793. 
(67)  Benzina, A.; Kruft, M. A. B.; van der Veen, F. H.; Bar, F. H.; Blezer, R.; Lindhour, T.; 
Koole, L. H. J. Biome Mater Res 1996, 32, 359. 
(68)  Horak, D.; Metalova, M.; Rypacek, F. J Biomed Mater Res 1997, 34, 183. 
(69)  Kruft, M. a; van der Veen, F. H.; Koole, L. H. Biomaterials 1996, 18, 31. 
(70)  Aldenhoff, Y. B. J.; Kruft, M.-A. B.; Pijpers,  a P.; van der Veen, F. H.; Bulstra, S. K.; 
Kuijer, R.; Koole, L. H. Biomaterials 2002, 23, 881. 
(71)  Rode, C.; Schmidt, A.; Wyrwa, R.; Weisser, J.; Schmidt, K.; Moszner, N.; Gottlöber, R.-
P.; Heinemann, K.; Schnabelrauch, M. Polym. Int. 2014, 63, 1732. 
(72)  Kiran, S.; Joseph, R. J. Biomed. Mater. Res. Part A 2014, 102, 3207. 
(73)  Sang, L.; Wei, Z.; Liu, K.; Wang, X.; Song, K.; Wang, H.; Qi, M. J. Biomed. Mater. Res. 
Part A 2014, 102, 1121. 
(74)  Tavernise, S. The New York Times. 2012, p A15. 
(75)  Larsen, E. R. Radiopaque Thermoset Polymer, 1986. 
	 28 
(76)  Habnouni, S. El; Blanquer, S.; Darcos, V.; Coudane, J. J. Polym. Sci. Part A Polym. 
Chem. 2009, 47, 6104. 
(77)  Habnouni, S. El; Darcos, V.; Coudane, J. Macromol. Rapid Commun. 2009, 30, 165. 
(78)  Nottelet, B.; Coudane, J.; Vert, M. Biomaterials 2006, 27, 4948. 
(79)  Wu, L.; Jin, C.; Sun, X. Biomacromolecules 2011, 12, 235. 
(80)  Lendlein, A.; Langer, R. Science 2002, 296, 1673. 
(81)  Mather, P. T.; Luo, X.; Rousseau, I. A. Annu. Rev. Mater. Res. 2009, 39, 445. 
(82)  Lendlein, A.; Langer, R. Science 2002, 296, 1673. 
(83)  Zhu, G.; Liang, G.; Xu, Q.; Yu, Q. J. Appl. Polym. Sci. 2003, 90, 1589. 
(84)  Yuan, D.; Chen, Z.; Xu, C.; Chen, K.; Chen, Y. ACS Sustain. Chem. Eng. 2015, 3, 2856. 
(85)  Saad, G. R.; Lee, Y. J.; Seliger, H. Macromol. Biosci. 2001, 1, 91. 
(86)  Takahashi, T.; Hayashi, N.; Hayashi, S. J. Appl. Polym. Sci. 1996, 60, 1061. 
(87)  Kim, B. K.; Shin, Y. J.; Cho, S. M.; Jeong, H. M. J. Polym. Sci. Part B 2000, 38, 2652. 
(88)  Muto, K.; Osaka Works Sumitomo Elec. Ind. Ltd. Osaka-shi, O. Polyethylene Heat 
Shrinkable Tube. 02254977.8, 2003. 
(89)  Chernous, D. A.; Shil’ko, S. V; Pleskachevshii, Y. M. J. Eng. Phys. Thermophys. 2004, 
77, 6. 
(90)  Li, Q.; Zhou, J.; Vatankhah-Varnoosfaderani, M.; Nykypanchuk, D.; Gang, O.; Sheiko, S. 
S. Macromolecules 2016, 49, 1383. 
(91)  Jackson, A. M. S.; Sheiko, S. S.; Ashby, V. S. Langmuir 2015, 31, 5489. 
(92)  Turner, S. A.; Zhou, J.; Sheiko, S. S.; Ashby, V. S. ACS Appl. Mater. Interfaces 2014, 6, 
8017. 
(93)  Yakacki, C. M.; Shandas, R.; Lanning, C.; Rech, B.; Eckstein, A.; Gall, K. Biomaterials 
2007, 28, 2255. 
(94)  Wache, H. M.; Tartakowska, D. J.; Hentrich, A.; Wagner, M. H. J Mater Sci Mater Med 
2003, 14, 109. 
(95)  Cui, J.; Kratz, K.; Lendlein,  a. Smart Mater. Struct. 2010, 19, 65019. 
(96)  Tuissi, A.; Carr, S.; Butler, J.; Gandhi, A. A.; O’Donoghue, L.; McNamara, K.; Carlson, J. 
M.; Lavelle, S.; Tiernan, P.; Biffi, C. A.; Bassani, P.; Tofail, S. A. M. Shape Mem. 
	 29 
Superelasticity 2016, 2, 196. 
(97)  Wang, S.; Guo, F. M.; Jiang, D. Q.; Liu, Y.; Cui, L. S. Scr. Mater. 2014, 81, 4. 
(98)  Lin, B.; Gall, K.; Maier, H. J.; Waldron, R. Acta Biomater 2009, 5, 257. 
(99)  Ebara, M.; Uto, K.; Idota, N.; Hoffman, J. M.; Aoyagi, T. Adv. Mater. 2012, 24, 273. 
(100)  Wong, Y. S.; Salvekar, A. V.; Zhuang, K. Da; Liu, H.; Birch, W. R.; Tay, K. H.; Huang, 
W. M.; Venkatraman, S. S. Biomaterials 2016, 102, 98. 
(101)  Langer, R. S.; Lendlein, A.; Annette, S.; Grablowitz, H. Biodegradable Shape Memory 
Polymers. 6160084, 2000. 
(102)  Langer, R.; Lendleim, A. Shape Memory Polymers. US 6388043 B1, 2002. 
(103)  Burattini, S.; Merino, D. H.; Weng, W.; Seppala, J.; Colquhoun, H. M.; Hayes, W.; 
Mackay, M. E.; Hamley, I. W.; Rowan, S. J. J. Am. Chem. Soc. 2010, 132, 12051. 
(104)  Faul, B. C. F. J.; Antonietti, M. Adv. Mater. 2003, 15, 673. 
(105)  Craig, S. L. Angew. Chemie 2009, 48, 2645. 
(106)  Li, H.; Wu, L. Soft Matter 2014, 10, 9038. 
(107)  Fox, J. D.; Rowan, S. J. Macromolecules 2009, 42, 6823. 
(108)  Beck, J. B.; Ineman, J. M.; Rowan, S. J. Macromolecules 2005, 38, 5060. 
(109)  Dong, S.; Zheng, B.; Wang, F.; Huang, F. Acc. Chem. Res. 2014, 47, 1982. 
(110)  Lillya, C. P.; Baker, R. J.; Hutte, S.; Winter, H. H.; Lin, Y.-G.; Shi, J.; Dickinson, L. C.; 
Chien, J. C. W. Macromolecules 1992, 25, 2076. 
(111)  Khakshoor, O.; Wheeler, S. E.; Houk, K. N.; Kool, E. T. J. Am. Chem. Soc. 2012, 134, 
3154. 
(112)  Sijbesma, R. P.; Beijer, F. H.; Brunsveld, L.; Folmer, B. J. B.; Hirschberg, J. H. K. K.; 
Lange, R. F. M.; Lower, J. K. L.; Meijer, E. W. Science 1997, 278, 1601. 
(113)  Keizer, H. M.; van Kessel, R.; Sijbesma, R. P.; Meijer, E. W. Polymer. 2003, 44, 5505. 
(114)  Folmer, B. J. B.; Sijbesma, R. P.; Versteegen, R. M.; van der Rijt, J. a. J.; Meijer, E. W. 
Adv. Mater. 2000, 12, 874. 
(115)  Kautz, H.; van Beek, D. J. M.; Sijbesma, R. P.; Meijer, E. W. Macromolecules 2006, 39, 
4265. 
(116)  Keizer, H. M.; Sijbesma, R. P.; Jansen, J. F. G. A.; Pasternack, G.; Meijer, E. W. 
	 30 
Macromolecules 2003, 36, 5602. 
(117)  Söntjens, S. H. M.; Sijbesma, R. P.; Van Genderen, M. H. P.; Meijer, E. W. J. Am. Chem. 
Soc. 2000, 122, 7487. 
(118)  Faghihnejad, A.; Feldman, K. E.; Yu, J.; Tirrell, M. V.; Israelachvili, J. N.; Hawker, C. J.; 
Kramer, E. J.; Zeng, H. Adv. Funct. Mater. 2014, 2322. 
(119)  Bastings, M. M. C.; Koudstaal, S.; Kieltyka, R. E.; Nakano, Y.; Pape,  a. C. H.; Feyen, D. 
a M.; van Slochteren, F. J.; Doevendans, P. a.; Sluijter, J. P. G.; Meijer, E. W.; 
Chamuleau, S. a J.; Dankers, P. Y. W. Adv. Healthc. Mater. 2014, 3, 70. 
(120)  Agnaou, R.; Capelot, M.; Tencé-Girault, S.; Tournilhac, F.; Leibler, L. J. Am. Chem. Soc. 
2014, 136, 11268. 
(121)  Biyani, M. V; Foster, E. J.; Weder, C. ACS Macro Lett. 2013, 2, 236. 
(122)  Shokrollahi, P.; Mirzadeh, H.; Huck, W. T. S.; Scherman, O. A. Polymer. 2010, 51, 6303. 
(123)  Botterhuis, N. E.; van Beek, D. J. M.; Gemert, G. M. L.; Bosman, A. W.; Sijbesma, R. P. 
J. Polym. Sci. Part A Polym. Chem. 2008, 46, 3877. 
(124)  Appel, W. P. J.; Portale, G.; Wisse, E.; Dankers, P. Y. W.; Meijer, E. W. Macromolecules 
2011, 44, 6776. 
(125)  van Beek, D. J. M.; Spiering, A. J. H.; Peters, G. W. M.; Te Nijenhuis, K.; Sijbesma, R. P. 
Macromolecules 2007, 40, 8464. 
(126)  van Beek, D. J. M.; Gillissen, M. A. J.; Van As, B. A. C.; Palmans, A. R. A.; Sijbesma, R. 
P. Macromolecules 2007, 40, 6340. 
(127)  Dankers, P. Y. W.; Zhang, Z.; Wisse, E.; Grijpma, D. W.; Sijbesma, R. P.; Feijen, J.; 
Meijer, E. W. Macromolecules 2006, 39, 8763. 
(128)  Deans, R.; Ilhan, F.; Rotello, V. M. Macromolecules 1999, 32, 4956. 
(129)  Ilhan, F.; Galow, T. H.; Gray, M.; Clavier, G.; Rotello, V. M. J. Am. Chem. Soc. 2000, 
122, 5895. 
(130)  Ilhan, F.; Gray, M.; Rotello, V. M. Macromolecules 2001, 34, 2597. 
(131)  Yamauchi, K.; Lizotte, J. R.; Hercules, D. M.; Vergne, M. J.; Long, T. E. J. Am. Chem. 
Soc. 2002, 124, 8599. 
(132)  Yamauchi, K.; Kanomata, A.; Inoue, T.; Long, T. E. Macromolecules 2004, 37, 3519. 
(133)  Houston, K. R.; Jackson, A.-M. S.; Yost, R. W.; Carman, H. S.; Ashby, V. S. Polym. 
Chem. No. PY-ART-08-2016-001421.R1. 
	 31 
(134)  Whinfield, J. R.; Dickson, J. T. Polymeric Linear Terephthalic Esters. 2465319, 1949. 
(135)  Sheirs, J.; Long, T. E. Modern Polyesters; John Wiley & Sons, Ltd.: West Sussex, 2003. 
(136)  Kodak; Kibler, C. J.; Bell, A.; Smith, J. G. Improvements in Linear Polyesters and 
Polyesteramides. 818157, 1956. 
(137)  Kodak, E.; Kibler, C. J.; Bell, A.; Smith, J. G. Linear Polyesters and Polyester-amides 
from 1,4-cyclohexanedimethanol. 2901466, 1959. 
(138)  Turner, S. R. J. Polym. Sci. Part A Polym. Chem. 2004, 42, 5847. 
 
 
  
	 32 
 
CHAPTER 2: IODINATED HOMOPOLYMERS AS A VERSATILE PLATFORM 
FOR RADIOPAQUE BIOMATERIALS AND NANOPARTICLES 
	
2.1 Introduction 
Computed tomography (CT) is a critical tool of modern diagnostic medicine.  CT 
generates detailed images used for diagnosing diseases and health conditions and for monitoring 
implants over the course of their lifetime.1–3  Therefore, polymeric implantable biomaterials that 
are capable of high x-ray contrast without sacrificing their thermal and mechanical properties are 
not only desirable but also critical for the ever-expanding scope of implantable biomaterials.12,13   
The conspicuity of implants in the acquired CT image is dependent on the electron 
density of the surrounding medium.  Replacing electron-dense metal-based implants with 
polymeric materials has many advantages:  tunable biodegradability, increased biocompatibility, 
and improved or adaptable mechanical properties.  However, these advantages sacrifice the 
ability to monitor an implant over the course of its lifetime because these biomaterials often lack 
radiocontrast with respect to the surrounding tissue.  This challenge has been overcome 
traditionally by the addition of metallic tags,4,5,14 the development of composites,15–17 or the 
covalent attachment of iodine-containing molecules to the polymer structure.9,10,18–28  For 
example, polymer-based medical devices, such as stents, incorporate gold or platinum metallic 
markers,4,5,14 thus directly contradicting the overall goal of complete device biodegradability.  
  Diagnostic radiology often requires general blood pool imaging of low-contrast soft 
tissues, such as the liver or bowel; thus, contrast agents containing barium or iodine are regularly 
utilized.3  However, traditional CT contrast agents suffer from limitations including rapid 
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excretion (typical distribution half-life of approximately 10 minutes), unspecific biodistribution, 
and renal toxicity.3,6  The production of radiopaque polymeric biomaterials could allow the 
realization of safer, more effective implants and CT contrast agents. 
Current research attempts to circumvent the complications connected to traditional 
contrast agents through the development of new iodinated liquids or mixtures,2 coordination 
polymers,7 copolymers and polymers based on methacrylates,8 anhydride esters,9 cellulose,10 
liposomes,3 and nanoparticles.6  Aviv et al. showed that polymer nanoparticles produced by the 
emulsion polymerization of 2-methacryloyloxyethyl(2,3,5-triiodobenzoate) provided significant 
contrast enhancement after 30 minutes and allowed for easy visualization of a cancerous mouse 
liver.8  While most of these developed materials are capable of satisfactory contrast, stability and 
toxicity remain problematic in some cases.3,11 
Though there is variance in the structure and delivery method of contrast agents, almost 
all iodine-based contrast materials described in the literature utilize aromatic ring-bound 
iodine.9,18,21,29  Many of these precursors are expensive and toxic; however, they presumably 
increase the stability of the bound iodine.  Few examples of aliphatic iodinated polymers exist;25–
27 new, aliphatic iodinated polymers could provide improved stability, safety (i.e., nontoxic), and 
biodegradability.  Herein, a novel, aliphatic, iodinated biomaterial platform is reported.  This 
platform exhibits: stability, radiopacity, low cost, versatile thermal and mechanical properties, 
and no cytotoxicity.  Furthermore, these materials can be processed into thermosets and lipid-
polymer hybrid nanoparticles.  The fabrication of nanoparticle contrast agents has the potential to 
increase the utility of x-ray computed tomography as a diagnostic and disease management tool 
for all patient populations. 
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2.2 Experimental Methods 
2.2.1 Materials 
All materials were purchased from Sigma-Aldrich, Fisher Scientific, or VWR 
International.  Water was filtered using a Milli-Q Advantage A10 Ultrapure Water Purification 
System for aqueous solutions and washings.  Millipore (Amicon Ultra) Centrifugal Filters with a 
100 kDa MWCO were used to purify and concentrate nanoparticle suspensions.  
Dichloromethane (CH2Cl2) was dried over CaH2 and distilled immediately before use. 
2.2.2 Characterization 
The monomers and prepolymers were characterized using a Bruker 400 AVANCE (1H 
and 13C NMR), a TA Instruments Q200 differential scanning calorimeter (DSC), a Perkin Elmer 
Pyris 1 thermogravimetric analyzer (TGA).  Gel permeation chromatography (GPC) was 
performed on a Waters 2695 Separations Module relative to polystyrene standards to 
characterize the prepolymers.  All films were characterized by DSC, TGA, and Instron Model 
5566 equipped with a 500 N load cell.  Elemental analysis was performed using an Oxford 
instruments, INCA PentaFET energy dispersive x-ray spectrometer (EDS) on a Hitachi S-4700 
cold cathode field emission scanning electron microscope (SEM), through Midwest Microlab 
LLC (monomer and polymers), and using a Kratos Axis Ultra DLD X--ray Photoelectron 
Spectrometer (XPS).  Nanoparticles were characterized using a Malvern Instruments nano ZS 
zetasizer dynamic light scattering (DLS) instrument, a JEOL 100 CX II transmission electron 
microscope (TEM), and a TA instruments Q5000 TGA.  DLS was performed at 25 °C and 
allowed to equilibrate for 120 seconds unless otherwise noted.   
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2.2.3 Synthesis 
2.2.3.a Synthesis of 2,2-bis(iodomethyl)-1,3-propanediol30,31  
In a nitrogen-purged flask equipped with a reflux condenser, 2,2-bis(bromomethyl)-1,3-
propanediol (50.0 g, 0.190 mmol) was added with sodium iodide (286 g, 1.90 mmol), followed 
by the addition of 1 L of acetone.  The reaction was refluxed for 3 days. Once the reaction had 
gone to completion, the solvent was removed, and the product was extracted with ethyl acetate 
(thrice) and DI water with 5% sodium thiosulfate (thrice).  The product was recrystallized in a 
solvent mixture of dichloromethane (400 mL) and acetone (<200 mL) to produce large white 
crystals, yield 56.5 g (83%).  1H NMR, acetone-d6, δ (ppm) 4.08 (t, J = 5 Hz, 2H), 3.59 (d, J =4 
Hz, 4H) and 3.34 (s, 4H).  13C NMR, acetone-d6, δ (ppm) 63.10 and 13.04.  Elemental analysis, 
calculated 16.86 %C, 2.83 %H, 71.31 %I, 8.99 %O; found 16.97 %C, 2.83 %H, 70.55 %I, 9.04 
%O.  
2.2.3.b Typical Polymerizations with 2,2-bis(iodomethyl)-1,3-propanediol and Diacids 
Various polymers were prepared via the polycondensation of 2,2-bis(iodomethyl)-1,3-
propanediol and the corresponding diacids:  succinic, adipic, and sebacic acid.  In a typical run 
using sebacic acid as the diacid, a dry flask was charged with 2,2-bis(iodomethyl)-1,3-
propanediol (3.250 g, 9.131 mmol), sebacic acid (1.776 g, 8.780 mmol), and scandium triflate 
(0.090 g, 0.182 mmol).  The flask was nitrogen purged before heating the reaction to 135 °C.  
After 1-2 hours, the temperature was lowered to 100 °C, and vacuum was reduced to 30 torr at a 
rate of 80 torr per hour.  This pressure was maintained for 24 hours, after which the vacuum was 
reduced to 0.3 torr for another 24 hours.  The polymerization was terminated by cooling the 
reaction mixture to room temperature, dissolving the polymer in CHCl3, and precipitating into 
cold methanol (-78 °C) and cold diethyl ether (-78 °C). 
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2.2.3.c Poly(2,2-bis(iodomethyl)-1,3-propylene succinate) 
1H NMR, CDCl3, δ (ppm) 4.16 (s, 4H), 3.57 (s, 0.23H), 3.30 (s, 4H), and 2.68 (s, 4H). 
13C NMR, CDCl3, δ (ppm) 171.40, 64.73, 40.05, 29.05, and 9.94. 
2.2.3.d Poly(2,2-bis(iodomethyl)-1,3-propylene adipate) 
1H NMR, CDCl3, δ (ppm) 4.11 (s, 4H), 3.56 (s, 0.23H), 3.29 (s, 4H), 2.37 (m, 4H), and 
1.68 (m, 4H). 13C NMR, CDCl3, δ (ppm) 172.37, 64.26, 39.93, 33.76, 24.36, and 9.49. 
2.2.3.e Poly(2,2-bis(iodomethyl)-1,3-propylene sebacate) 
1H NMR, CDCl3, δ (ppm) 4.09 (s, 4H), 3.47 (s, 0.H), 3.28 (s, 4H), 2.32 (t, J = 7.4 Hz, 
4H), 1.61 (t, J = 6.1, 4H), and 1.3 (s, 8H). 13C NMR, CDCl3, δ (ppm) 172.82, 64.00, 39.78, 
34.10, 29.03, 24.88, and 9.38. 
2.2.3.f Polymer End-capping with 2-Isocyanatoethyl Methacrylate 
In a typical run, a dry round bottom flask was charged with the iodinated polymer (4.0 g, 
0.96 mmol), and purged with nitrogen before the addition of dry CH2Cl2 (24 mL).  The 2-
isocyanatoethyl methacrylate (0.57 mL, 3.8 mmol) was added, followed by the dropwise addition 
of tin(II) ethylhexanoate (20 µL, 0.05 mmol).  The reaction was stirred for 24 hours at room 
temperature.  The reaction was terminated by precipitation into cold methanol (-78 °C) or cold 
ether (-78 °C).  The prepolymer was dried in vacuo at room temperature for 24 hours before use 
and stored at 4 °C. 
2.2.3.g End-capped Poly(2,2-bis(iodomethyl)-1,3-propylene succinate) 
1H NMR, CDCl3, δ (ppm) 6.13 (m, 0.18H), 5.61 (m,0.18H), 4.23 (m, 0.66H), 4.15 (s, 
4H), 3.49 (m, 0.38H), 3.30 (s, 4H), 2.67 (s, 4H), and 1.95 (d, J = 8 Hz, 0.56H). 
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2.2.3.h End-capped Poly(2,2-bis(iodomethyl)-1,3-propylene adipate)  
1H NMR, CDCl3, δ (ppm) 6.13 (m, 5.60 (m, 0.23H), 5.60 (m, 0.21H), 4.23 (m, 0.48H), 
4.10 (s, 4H), 3.50 (m, 0.41H), 3.28 (s, 4H), 2.37 (m, 4H), 1.97 (d, J = 8 Hz, 0.72H), and 1.67 (m, 
4H). 
2.2.3.i End-capped Poly(2,2-bis(iodomethyl)-1,3-propylene sebacate) 
1H NMR, CDCl3, δ (ppm) 6.18 (s), 5.64 (s), 4.29 (t, J = 6 Hz), 4.24 (m), 4.09 (s, 4H), 
3.56 (t, J = 8 Hz), 3.51 (m), 3.28 (s, 4H), 2.32 (t, J = 7.4 Hz, 4H), 1.95 (s), 1.61 (t, J = 6.1, 4H), 
and 1.3 (s, 8H). 
2.2.4 Thermoset Fabrication 
A prepolymer solution (2 g mL-1 in CHCl3) containing approximately 2% b.w. 
diethoxyacetophenone was cast into a mold or onto a glass slide.  The mold was then placed in a 
UV chamber (ELC-500 Light Exposure System) for 10 minutes under a flow of N2. The film was 
placed in a vacuum oven at 70 °C for 24 hours under high vacuum. 
2.2.5 Preliminary Thermoset Degradation by Hydrolysis 
Films of known weight were placed in 1 mL of 10 mM pH 7.4 phosphate buffered saline 
(PBS) solution at 37 °C.  The films were removed from the buffer solution at prescribed intervals 
and dried under vacuum for 24 hours before their masses were measured.  Each measurement was 
performed on three separate samples.  Mass loss (ML) was calculated according to the following 
equation, where mi is the initial mass and mf is the final mass: 
…………………………. (equation 2.1). 
2.2.6 Typical Liposomal-nanoprecipitation 
Stock solutions of PEG-monostearate (n=55) and lecithin were prepared separately at 
concentrations of 2 mg mL-1 and 1 mg mL-1 in 4% b.v. ethanol aqueous solutions, respectively.  
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Stock solutions of prepolymer were prepared at a concentration of 2.5 mg mL-1 in HPLC-grade 
DMF.  PEG-monostearate (21.68 mL) and lecithin (1.25 mL) solutions were then added to 228 
mL purified water.  The photoinitiator, 2,2-diethoxyacetophenone, (0.0116 g, 0.0557 mmol) was 
added to 43.4 mL of the polymer solution, which was then poured into the aqueous 
phospholipid/lipid-PEG solution, such that the ratio of polymer to phospholipid/lipid-PEG was 
equal to 2.4:1.  Once the prepolymer solution was added, water (206 mL) was promptly added to 
the mixture, so that the final volume ratio of pure water to organic solution was 10:1.  The 
resulting mixture was sonicated for 10 minutes using a Branson 1510 bath sonicator at a 
frequency of 42 kHz and power of 70 W.  The particles were then irradiated with UV light for at 
least 20 minutes.  The nanoparticle suspensions were purified and concentrated by centrifugation 
using Millipore filters and were stored at 4 °C.  The method described was used in the majority 
of the experiments described in this thesis.  Other formulations varied the ratios of solutions or 
the concentration of either the aqueous or organic solutions.  In some cases, DSPE-PEG was 
used instead as the lipid conjugated PEG.  This general method was used in traditional 
nanoprecipitation methods without the addition of a lipid-PEG or stabilizer to the aqueous phase.  
2.2.6.a Core-crosslinking  
A nanoparticle suspension was charged to a round bottom flask then sealed.  Argon was 
bubbled through the suspension for 30 minutes to purge any oxygen present.  The suspension 
was then placed in a broad spectrum UV chamber (ELC-500 Light Exposure System) for 10 
minutes under a steady flow of N2 (to maintain the temperature at approximately 25 °C).  After 
exposure to UV radiation, the suspension was lyophilized and dissolved in CDCl3 for 1H NMR.   
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2.2.7 Nanoparticle Stability Tests 
2.2.7.a Nanoparticle Stability at Body Temperature 
 Nanoparticle suspensions (100 nm, PDI = 0.14) at concentrations of 1.0 mg mL-1 and 3.4 
mg mL-1 were incubated in a 37 °C water bath.  DLS was performed at 37 °C (300 second soak) 
after 1 hour of incubation (1.0 mg mL-1:  99 nm, PDI = 0.11; 3.4 mg mL-1:  100 nm, PDI = 0.11) 
and 1 day of incubation (1.0 mg mL-1:  98 nm, PDI = 0.10; 3.4 mg mL-1:  100 nm, PDI = 0.10).  
TEM was performed on the more concentrated nanoparticles after 1 day of incubation and 
compared to a sample of unheated nanoparticles made from the same formulation batch at the 
same concentration. 
2.2.7.b Whole Blood and Serum Aggregation Studies 
 A nanoparticle suspension (82 mg mL-1) was added to both serum and whole blood at 
ratios of 1:1, 1:10, and 1:100.  For the ratio of 1:1 (nanoparticle suspension to whole 
blood/serum), the liquids were mixed on a slide and viewed under the microscope immediately.  
Ratios of 1:10 and 1:100 were mixed in Eppendorf tubes and viewed approximately 2 minutes 
after mixing.  
2.2.8 Cytotoxicity 
To assess the biocompatibility of the crosslinked films, 20,000 murine alveolar 
macrophages (ATCC CCL-2019) were seeded into 24 well plates in 1mL of complete RPMI 
1640 containing 0.05mM 2-mercaptoethanol and 10% fetal bovine serum per well.  Cells were 
allowed to adhere for 24 hours and subsequently incubated with the crosslinked films, which 
were placed into Falcon cell culture inserts containing a 3µm pore size.  One milliliter of 
complete medium was added to each insert and cells/crosslinked films were incubated for an 
additional 72 hours in a 37°C, 5% CO2 incubator.  After the 72-hour incubation period, cell 
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culture inserts were removed and all medium was aspirated off cells.  300µL of fresh medium 
was added back to each well followed by the addition of 300µL CellTiter-Glo® Luminescent 
Cell Viability Assay reagent (Promega, Madison WI).  Plates were placed on a microplate shaker 
for 2 minutes, incubated at RT for 10 minutes to stabilize luminescent signal.  The luminescent 
signal was recorded on a Molecular Dynamics SpectraMax M5 plate reader.  Cell viability was 
expressed as a percentage of the luminescent signal of cells grown in the absence of crosslinked 
film (cells only in complete medium).  Each measurement was performed in triplicate with three 
independently prepared batches of polymeric material. 
2.2.9 In Vitro X-ray Images and Projections 
X-ray projections and images were taken with a novel carbon-nanotube cathode x-ray 
source with a tungsten anode and 0.2 mm Be and 0.5 mm Al filtration, at 50 kVp energy.32  For 
the in-air experiments, polymer films with dimensions of approximately 30 x 3 x 3 mm were 
used.  For the in-tissue experiments, polymer films (4 x 2 x 2 mm) were implanted into porcine 
liver segments (15 mm cubes).  Nanoparticles were suspended in water at different 
concentrations (150 to 450 mg mL-1) to obtain x-ray projections. 
2.2.10 In Vivo CT Imaging 
In vivo imaging was performed under the permission of The University of North Carolina 
at Chapel Hill Institutional Animal Care and Use Committee (IACUC), protocol number 12-
184.0B.  Female Balb/C mice were purchased from Charles River (5-7 weeks old).  CT images 
were performed using a Gamma Medica, Inc. eXplore CT-120 (70 kVp, 50 mA) prior to the tail 
vein injection of nanoparticles (120 µL, 130 mg I/mL).  Another mouse was administered 
OMNIPAQUE® 300 (iohexol, 120 µL, diluted with saline to 150 mg I/mL).  Time points were 
taken immediately followed by 5 minute intervals until reaching 30 minutes.  The mouse 
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administered the nanoparticles was imaged again 1 hour after injection.  The mice were 
anesthetized and maintained using inhalation anesthesia (1.5% isoflurane in 1:2 O2/N2).  The 
mouse administered with OMNIPAQUE® 300 was sacrificed 30 minutes after the imaging 
procedure, and the mouse administered the nanoparticles was sacrificed upon completion of the 
60-minute imaging procedure.  Images were processed using ImageJ software. 
2.3 Results and Discussion 
2.3.1 Monomer Synthesis 
 The key to the synthesis of the materials described herein is the aliphatic iodine 
component, 2,2-bis(iodomethyl)-1,3-propanediol (Scheme 2.1).  This monomer is resistant to 
thermal degradation, which is evident through its high thermal degradation of 5% b.w. at 201 °C 
(Table 2.1).  Furthermore, 2,2-bis(iodomethyl)-1,3-propanediol can be stored at ambient 
temperatures without special UV protection.   
 
 
 
Scheme 2.1 Synthesis of 2,2-bis(iodomethyl)-1,3-propanediol. 
 
Table 2.1 Properties of 2,2-Bis(iodomethyl)-1,3-propanediol. 
 
Most aliphatic iodinated compounds degrade easily at room temperature, when exposed 
to light, or in the presence of nucleophiles, thus yielding far more stable elimination or 
Tm (° C)a ΔH (J g-1)a 5% (°C)b 10% (°C)b Calculated %I Experimental %Ic 
130.7 93.0 201 216 71.36 71.16 
 
a DSC, first heat 10 °C min-1; b Decomposition measured by TGA 20 °C min-1; c Measured by 
elemental analysis. 
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substitution products.  2,2-Bis(iodomethyl)-1,3-propanediol is resistant to elimination products 
(loss of iodine to produce an alkene) because the resulting molecule would have a fifth, 
forbidden bond to carbon.  Furthermore, substitution as a side reaction is suppressed as a result 
of steric hindrance.  This is evident, as the simple Finkelstein reaction utilized to produce 2,2-
bis(iodomethyl)-1,3-propanediol took several days at reflux to reach full conversion (Scheme 
2.2).  Recrystallization yielded monomer of high purity (determined by elemental analysis, Table 
2.1 and Table A1-A2 from Appendix A).  These properties permit the manufacture of polymers 
at various temperatures (80 to 140 °C) without degradation of the starting materials. 
2.3.2 Polymer Synthesis and Evaluation 
2.3.2.a Prepolymers 
 The iodinated monomer was polymerized with succinic, adipic, and sebacic acids 
(Scheme 2.2).  For convenience, the iodinated polymers will be identified by their respective 
diacid co-monomers (i.e., succinic (Su), adipic (Ad), and sebacic (Se) acid).  Scandium(III) 
triflate, which is insensitive to halogens, was utilized as the catalyst.33  More traditional catalysts, 
such as lipases and tin(II) ethylhexanoate, were ineffective due to limitations of reaction 
temperature (i.e., lipases), polymer molecular weight, or purity.  By utilizing scandium(III) 
triflate, polyesters with number-average molecular weights between 4400 and 5700 g mol-1 and 
dispersity of 1.4 - 1.5 (Đ lower than 2 due to fractionation upon purification) were produced, as 
shown in Table 2.2. 
The prepolymers were amorphous, with glass transition temperatures between -3 and  
-45 °C (Table 2.2).  The thermal degradation temperatures of these materials matched the 
expected degradation temperatures of typical aliphatic polyesters.34  The iodinated monomer had 
a significantly lower degradation temperature (5% weight loss at 201 °C, Table 2.1) than the 
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polymers (5% weight loss at 210-290 °C).  The increase in thermal stability of the iodinated 
monomer indicates that the monomer was stabilized upon incorporation into the polymer chain.   
 
 
Scheme 2.2 Synthesis of iodinated polyesters followed by photo-crosslinking to yield iodinated 
thermosets. 
 
Table 2.2 Iodinated Polymer Properties. 
Polymer 
(by diacid) 
Mn 
(g mol-1)a 
<Mn> 
(g mol-1)b 
<Mw> 
(g mol-1)b Đ
b 5% (°C)c 
Tg 
(°C)d 
Succinic 4400 5500 7700 1.4 290 -3 
Adipic 5600 5900 9000 1.5 270 -30 
Sebacic 5700 7800 11000 1.5 210 -45 
 
a Measured by 1H NMR (400 MHz in CDCl3). b Measured by GPC in THF using polystyrene 
standards.  c Measured by TGA.  d Measured by DSC, mid-point of the second heat. 
Iodinated Thermoset
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2.3.2.b Thermosets 
Because the prepolymers were viscous liquids at room temperature, they were end-
functionalized with a methacrylate group to yield macromonomers.  These macromonomers were 
UV crosslinked into thermoset elastomers to impart improved mechanical properties (Table 2.3).  
The sebacic acid and adipic acid based polymers had high maximum strains (>100%) and low 
moduli (between 0.6 and 5 MPa).  The succinic acid based polymer had a much higher modulus 
(55 MPa) and a lower maximum strain.  Facile crosslinking of the polymers was of particular 
interest because crosslinking could potentially produce stabilized nanoparticles.  Although 
nanoparticle fabrication was the ultimate goal, the properties of the elastomers were analyzed 
thoroughly.   
In addition to improved mechanical properties, the glass transition temperatures of the 
polymers increased as a result of crosslinking.  The thermal properties of the elastomers varied 
depending on the diacid used and on the molecular weight of the prepolymers (Table 2.3).  
Similar to the trend observed in the prepolymers, the Tg of the elastomers decreased as the 
hydrocarbon spacer of the diacid comonomer increased (m = 1, 2, or 4; Scheme 2.2), varying 
from -1 to -16 °C.  Glass transition temperatures as high as 16 °C were achieved when the 
succinic acid based polymer molecular weight was increased to 7,000 g mol-1 (Table A3, 
Appendix A).  
The hydrolytic degradation of the adipic acid based thermoset was tested over the course 
of 20 days in a solution of PBS at 37 °C.  Only 2.3% mass loss was observed.  The slow 
hydrolytic degradation of this polymer is most likely due to a combination of chemical crosslinks 
and the hydrophobicity and steric effects of the iodinated monomer.35  The incorporation of a 
PEG copolymer allowed for a slight increase in mass loss (approximately 5% mass loss over 20 
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days).  Further studies are necessary to confirm that this mass loss was due to polymer 
degradation and was not due to the leaching of small molecules or oligomers. 
 
Table 2.3 Thermoset Properties. 
Polymer 
(by diacid) Tg (°C)
a
 5% (°C)b 
E 
(MPa)c,* 
Strain 
(%)c,* 
Succinic -1 290 55.4 21 
Adipic -11 340 4.9 140 
Sebacic -16 370 0.6 222 
 
a DSC, second heat 10 °C min-1. b Decomposition measured by TGA. c Measured by Instron, 
Young's modulus (E) and strain at break at 25 °C at 10 mm min-1. * Measured using polymers in 
Table A3 of Appendix A. 
 
 
2.3.3 Bulk Polymer Radiopacity 
Because radiopacity is directly related to iodine content, the amount of iodine 
incorporated into the polymers was analyzed.  1H NMR was used to determine the iodine content 
of the prepolymers before crosslinking.  Peaks associated with the iodinated unit were compared 
with peaks associated with the diacid unit (Appendix A, Figures A3-A5).  After UV crosslinking, 
the thermosets were analyzed by EDS.  The thermosets exhibited very high iodine contents by 
EDS (>60%, Table 2.4).  Minimal iodine loss was apparent when comparing the EDS results 
after UV crosslinking (a semi-quantitative technique) to the weight percent of iodine calculated 
by 1H NMR prior to crosslinking (Figure 2.1).  Furthermore, the crosslinked thermosets 
exhibited little to no color change, thus indicating minimal iodine loss (Appendix A, Figure 
A15).36  The lack of color change and the high iodine values measured by EDS suggest that 
iodine content does not differ significantly as a result of UV exposure. 
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Table 2.4 EDS Results for the Crosslinked Bulk Materials and Nanoparticles. 
Element Wt% Element in Sample Se Ad Su Ad-NP 
C 24 17 17 35 
I 68 72 72 52 
 
 
Figure 2.1 Comparison of the weight percent of iodine using 1H NMR and EDS before and after 
crosslinking. 
	
The high iodine content of these materials was visually apparent in CT images.  Figure 
2.2 shows CT images of crosslinked rods of each iodinated material in air (inset).  To illustrate 
that these materials are easily visualized within tissue, they were implanted into cut segments of 
porcine liver and imaged (Figure 2.2).  The contrast of these materials decreases only slightly 
upon implantation. 
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Figure 2.2 CT images of iodinated polyester materials. From left to right: sebacic (Se), adipic 
(Ad), and succinic (Su) acid based thermosets implanted in porcine liver and in air (insets). 
	
2.3.4 Nanoparticle Synthesis and Evaluation 
2.3.4.a Modified Liposomal-nanoprecipitation Formulation 
Nanoparticles were synthesized using a modified liposomal-nanoprecipitation method 
(Figure 2.3).37,38  This method was selected to coat the hydrophobic nanoparticle core with PEG, 
which is well known to increase in vivo circulation times and potentially reduce the amount of 
iodine needed for good contrast (permitting a lower injection dose, I.D.).11,39  Nanoparticles were 
also made using a traditional nanoprecipitation method without PEG.  While highly 
monodisperse nanoparticles could be formulated without PEG (PDIs of 0.01-0.07), they were too 
large (>400 nm) and easily aggregated in water (Table A4).  Thus, the PEG corona also allowed 
easy dispersion of the nanoparticles in water.37,38 
To make the lipid-polymer hybrid nanoparticles, a solution of iodinated polymer in DMF 
was added to an aqueous solution containing a lipid-conjugated PEG (i.e., monostearate) and 
lecithin, a phospholipid stabilizer.  As the DMF mixed with the water, the hydrophobic polymer 
chains collapsed into nanoparticles.  The resulting mixture was sonicated for 10 minutes to allow 
kinetic self-assembly of the lipids on the surface of the precipitated polymeric particles.   
 
air 
Su liver Ad 
air 
liver Se 
air 
liver 
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Figure 2.3 Nanoparticle formulation method using a modified liposomal-nanoprecipitation 
method. 
	
2.3.4.b Evaluation of the Lipid-polymer Hybrid Nanoparticles 
Nanoparticles between 50 and 150 nm were targeted because particles within this size 
range are typically removed by the liver and spleen rather than by the kidneys.40  The modified, 
liposomal-nanoprecipitation procedure resulted in nanoparticles of approximately 75 nm with an 
average PDI of 0.11 for the succinic acid based particles (Su-NP), 82 nm with an average PDI of 
0.11 for the adipic acid based particles (Ad-NP), and 89 nm with an average PDI of 0.12 for the 
sebacic acid based particles (Se-NP), as seen in Figure 2.4.  EDS analysis of the particles showed 
high concentrations of iodine, only slightly lower than the bulk materials (Table 2.4).  The slight 
decrease in weight percent iodine provides evidence that the nanoparticles remained coated in 
lipid-PEG after purification. 
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Figure 2.4 Analysis of the size and shape of the lipid-polymer hybrid nanoparticles.  A) 
Dynamic light scattering results from the liposomal-nanoprecipitation method showing that the 
lipid-polymer hybrid nanoparticles were of similar size and PDI for all of the iodinated 
polymers.  B) TEM image depicting the nanoparticles made using the adipic acid based polymer, 
Ad-NP (scale bar = 200 nm).   
 
2.3.4.c Nanoparticle Stability at Body Temperature 
 To evaluate the stability of the nanoparticles, Ad-NP samples were incubated at 37 °C, 
and particle characteristics (size and PDI) were measured using DLS at time points of 1 hour and 
24 hours to monitor if aggregation would occur.  As shown in Figure 2.5, no significant change 
in size or PDI was noted during the incubation period, suggesting that the nanoparticles were 
stable when heated to body temperature.  The particles remained at approximately 100 nm with 
PDIs of 0.1 over the course of 24 hours.  
 
0.0
0.2
0.4
0.6
0.8
1.0
1 10 100 1000
Re
la
tiv
e 
In
te
ns
ity
Particle Diameter (nm)
Succinic Acid
Adipic Acid
Sebacic Acid
Su-NP
Ad-NP
Se-NP
B)A)
200 nm
	 50 
 
Figure 2.5 The nanoparticles were formulated in the same batch (RT = room temperature and 
BT = body temperature, 37 °C).  The hydrodynamic diameter of the nanoparticles were analyzed 
using DLS before and after incubation at 37 °C and also compared with nanoparticles stored at 
room temperature. 
 
2.3.4.d Nanoparticle Crosslinking 
 The nanoparticles reported to this point were not successfully crosslinked; however, 
crosslinking of the polymer core was of interest.  Three Ad-NP suspensions were prepared using 
the same stock solutions of polymer, lipid-PEG, and lecithin.  The photoinitiator was not added 
to one of the formulation batches as a control, and the resulting nanoparticles were stored away 
from light until further characterization was performed.  In another batch, the photoinitiator was 
added to the nanoparticle suspension, and the suspension was exposed to UV light for 10 
minutes.  The 1H NMR spectrum showed that this initial crosslinking method was not effective, 
presumably due to oxygen in the system, which prevented any radical reactions from occurring 
(Figure 2.6).  As depicted in Figure 2.6, these nanoparticles showed the same 1H NMR peak 
shifts and integrations as the formulation that had no UV exposure.  To rectify this problem, 
another Ad-NP suspension was made with the addition of photoinitiator; this suspension was 
purged with argon in an airtight container (30 minutes for a 50 mL suspension).  Crosslinking 
occurred after exposure to UV light for 10 minutes.  Crosslinking was verified by 1H NMR based 
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on the disappearance of the methylene peaks at 6.13 and 5.61 ppm (Figure 2.6).  1H NMR of the 
Ad-NP suspension that was argon purged and irradiated showed only the expected spectral peaks 
of the lipid-PEG/stabilizer portion of the nanoparticles because the crosslinked polymer was not 
soluble in CDCl3.41   
 
 
Figure 2.6 1H NMR spectra of A) Nanoparticle suspension that was successfully crosslinked 
(argon purged and UV irradiated), B) Nanoparticle suspension that was not crosslinked (no purge 
prior to irradiation), and C) Control nanoparticle suspension that had no addition of 
photoinitiator or UV exposure. 
 
2.3.5 In Vitro Cytotoxicity  
The cytotoxicity of the crosslinked films and lipid-polymer hybrid nanoparticles is shown 
in Figures 2.7 and 2.8.  No cytotoxicity was found for the bulk crosslinked films, and the 
nanoparticles showed no cytotoxicity up to 400 µg mL-1.  The cytotoxicity of these nanoparticles 
compares favorably against liquid contrast agents such as Fenestra VC, which displays 
significant cytotoxicity at <100 µg I mL-1. 42  The nanoparticles in this study do not show 
A)
B)
C)
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cytotoxicity until >100 µg I mL-1.  The percent viability was found using a CellTiter-Glo® 
luminescent cell viability kit to determine the amount of bioluminescent ATP present in the cells 
after 3 days of incubation.  Each measurement was performed in triplicate, with three 
independently prepared batches of polymeric material. 
 
 
Figure 2.7 Cytotoxicity of crosslinked films after 3 days of incubation. 
 
 
Figure 2.8 Cytotoxicity of nanoparticles at different concentrations. 
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2.3.6 Nanoparticle Radiopacity 
2.3.6.a In Vitro Radiopacity 
The effectiveness of the nanoparticles as general blood pool contrast agents was 
evaluated.  CT images of nanoparticle dispersions showed high contrast when compared to DI 
water and a commercial contrast agent, Omnipaque® 300 (Figure 2.9).  The attenuation was 
dependent on both concentration and particle type.  As expected, the particles incorporating the 
succinic acid based polymer (highest iodine content) showed the highest contrast, and the 
contrast increased with increasing concentration of suspended nanoparticles (Figure 2.9).  
 
      
Figure 2.9 X-ray projections of succinic, adipic, and sebacic acid based nanoparticles of 
different concentrations (roughly 150 to 450 mg/mL). 
	
2.3.6.a In Vivo Radiopacity 
The adipic acid based nanoparticles were used in a preliminary in vivo study.  These 
nanoparticles were made on a large scale, purified using sterile water, and concentrated to 
approximately 130 mg I mL-1.  Their size was analyzed by DLS prior to injecting the particles 
into the tail vein of a Balb/C mouse (Table 2.5).  The nanoparticles were approximately 94 nm 
Increasing Concentration
Sebacic acid
Adipic acid
Succinic acid
DI Water Omnipaque® 300
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with a PDI of 0.09, and the sample was prepared such that the I.D. would be 120 µL.  One 
female Balb/C mouse was imaged with no administered contrast agents; the consequent 
Hounsfield units (HU) values obtained from this negative control were used to find ΔHU when 
analyzing the CT images of the mice injected with contrast agents.  Another mouse was injected 
with Omnipaque (120 µL I.D., 150 mg I mL-1) as a positive control.  CT imaging was performed 
immediately after injection followed by time points at 5 minute intervals until reaching 30 
minutes for both mice (Figure A16-A17, Appendix A), and an additional time point was taken 60 
minutes after injection of the mouse administered the nanoparticles.   
 
Table 2.5 Nanoparticle Size Before and After Injection. 
Particle Size (d.nm) PDI 
Ad-NP before injection 1 93.5 0.1 
Ad-NP before injection 2 94.0 0.1 
Ad-NP before injection 3 93.8 0.1 
Ad-NP after injection 1 96.7 0.1 
Ad-NP after injection 2 96.9 0.1 
Ad-NP after injection 3 97.0 0.1 
 
In Figure 2.10, the nanoparticles (Ad-NP) showed comparable contrast to the clinically 
used contrast agent at the 30-minute time point, and Ad-NP contrast was long-lasting (observed 
over 60 minutes).  The nanoparticles bypassed the kidneys completely, whereas the commercial 
agent displayed immediate excretion and high attenuation in the kidneys (Figure 2.10 and Figure 
2.11).  The enhanced contrast observed in the mouse administered the nanoparticles suggests that 
nanoparticle contrast agents made from the iodinated polyesters synthesized herein have the 
potential to greatly increase blood pool attenuation and circulation.  
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Figure 2.10 Graph displaying contrast comparison against a control (no contrast injected) for the 
heart, liver, spleen, and kidneys. 
 
Although the mouse administered Ad-NPs showed healthy vital signs through the course 
of the imaging experiment, aggregation in the lungs was apparent (Figure A17, Appendix A).  
Aggregation can lead to acute lung embolism; therefore, the study was ended after one hour.  
The mice were sacrificed and organs were dissected for pathology.  A histological analysis 
implied the development of acute pulmonary edema (Figure A18, Appendix A).  Nanoparticle 
aggregation is a common challenge in the field.43,44  This aggregation presumably depends on the 
interplay between characteristics, such as hydrophobicity of the nanoparticle interior and the 
kinetic stability of the lipid-PEG corona.  To ensure that the aggregation occurred due to 
interactions within the murine body and not as a result of the injection process, DLS was 
performed on nanoparticles taken from the same batch and ejected with a syringe of the same 
gauge as the in vivo study.  The nanoparticles were only an average of 3 nm larger 
(approximately 97 nm), and there was no change in the PDI as a result of injection (Table 2.5). 
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Figure 2.11 CT images of mice injected with no contrast (control, top), a clinically used contrast 
agent (Omnipaque®, middle) and with the adipic acid based nanoparticles (Ad-NP, bottom).  
The red arrows indicate significant contrast in the bladder and kidneys for the commercial 
contrast agent. 
	
The stability of the nanoparticles was tested further in serum and whole blood.  This 
experiment provided valuable information about the potential in vivo behavior of the particles.  
Low kinetic stability of the PEG shell anchored to the hydrophobic polymer core could result in 
coalescence, particularly for the nanoparticles used in vivo, which were not crosslinked.44,45  A 
crosslinked nanoparticle suspension was added to mouse serum and whole blood at ratios of 1:1, 
1:10, and 1:100.  The mixture consisting of a 1:10 ratio Ad-NP to serum/whole blood most 
closely simulated the dilution of the particles if they were administered to a mouse with an 
injected dose of 200 µL.  The mixtures were viewed under a microscope and compared to pure 
Control
Ad-NP
OMINPAQUE
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serum and whole blood samples to see if any visible aggregates would form.  Aggregates up to 
5x the size of the surrounding red blood cells were observed (Figure 2.12).  These aggregates 
were large enough to cause congestion in the capillary bed of the lungs.  Studies have shown that 
the adsorption of blood plasma proteins increases as particle surface hydrophobicity 
increases.43,46  The observed aggregation in Figure 2.12 suggests that the lipid-PEG shell 
surrounding the particle was not stable, even after core crosslinking, thus exposing the 
hydrophobic core in vivo and causing proteins to attach.  
 
 
Figure 2.12 Micrograph showing aggregation in serum.  Circles drawn in to indicate where 
aggregation took place. 
 
2.4 Conclusions 
A series of iodinated polyesters were synthesized and evaluated.  These polyesters have 
the potential to serve as radiopaque biomaterials and blood pool contrast agents.  This versatile 
platform of wholly aliphatic, highly iodinated materials allows easy processability and tunable 
chemical and physical properties.  These iodinated polymers provided excellent contrast in air 
and imbedded in tissue (porcine liver).  Additionally, these polymers exhibited no cytotoxicity.  
By using a modified liposomal-nanoprecipitation method to make nanoparticles, these materials 
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showed great potential as an alternative to standard liquid contrast agents, as they have good 
attenuation and do not uptake in the kidneys; however, stability remained problematic.  The work 
presented here illustrates a new platform for the development of next-generation radiopaque 
biomaterials that have: modular physical and chemical properties, high radiopacity, low cost, 
easy processability, and sound biocompatibility.  
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CHAPTER 3: RADIOPAQUE SHAPE MEMORY MATERIALS VIA IODINATED 
COPOLYESTERS 
	
3.1 Introduction 
Shape memory polymers are a class of smart materials that can be programmed into a 
temporary shape by the application of a stimulus and force.  The temporary shape will remain 
until the material is recovered by exposing the material to the stimulus, such as heat or light.1–3  
Over the last several decades, shape memory polymers have been developed for biomedical 
applications, such as self-tying sutures,2 deployable stents,4,5 and dynamic tissue-engineering 
scaffolds.6–8  In many cases, however, shape memory polymers lack radiopacity due to the 
absence of high Z elements.  Therefore, although shape memory polymers can significantly 
lower the invasiveness of implantation,9 many are unable to be monitored by imaging 
technologies, like computed tomography (CT). 
The first examples of radiopaque shape memory materials appeared in the fabrication of 
radiopaque shape memory alloys;10,11 however, shape memory polymers are not only less 
expensive than shape memory alloys but also are considered more environmentally friendly.12  
For example, shape memory alloys are given radiocontrast through fabrication with elements, 
such as tungsten, platinum, or erbium.10,11,13   
Many of the shape memory polymers that also have x-ray contrast proficiency are 
provided radiocontrast through impregnation using inorganic salts and particles or contrast 
agents.6,7,14–16  For example, a mechanically active, shape memory scaffold was designed by 
Lendlein and coworkers.6  This shape memory material (an aliphatic polyether urethane, PEU) 
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was impregnated with up to 40% b.w. BaSO4 microparticles in order to induce radiopacity.  The 
resulting material showed good shape memory capabilities and x-ray contrast; however, the PEU 
selected for this study was not biodegradable.6  Biodegradability was presumably not a desired 
property of this shape memory system, as leaching of BaSO4 would cause the polymer to lose its 
radiopacity prematurely.  The leaching of inorganic salts, such as BaSO4, into the body has been 
documented as a possible risk due to the toxicity of the metal ions.17  Furthermore, impregnation 
using inorganic radiopaque additives can cause undesirable discoloration and limit pigment 
options of the material in its final form.18 
There are several inherently radiopaque polymers (covalently bound iodine) capable of 
shape memory; however, none of these materials were studied as “smart” biomaterials.  
Thermoplastic polyurethanes (TPUs), which utilize chemically bound, aromatic iodine in the 
crosslinker or in the hard segment of the TPU, are expected to exhibit shape memory 
capabilities.19–24  These inherently radiopaque TPUs, however, possess some drawbacks.  First, 
many of these polymers utilize monomers that result in non-biodegradable polymer systems.  
Secondly, several of these systems utilize an iodinated version of bisphenol-A (BPA), which has 
been banned from use in some applications by the FDA.25  In order to design a biodegradable 
TPU system, Y. Li and coworkers developed a TPU based on polybutylene succinate.  While this 
material showed radiocontrast and biodegradability, it utilized iodinated BPA in its hard 
segment.23   
Additionally, an aliphatic iodinated poly(caprolactone) (PCL) was synthesized.26–28  
While this polymer was not tested as a shape memory material, PCL is a well-known shape 
memory polymer.9,29  However, this polymer contains secondary iodides that are capable of SN1, 
SN2, E1, and E2 side-reactions.   
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In this report, copolymers incorporating an aliphatic, iodinated monomer were developed.  
The synthesis of copolymers allowed for the addition of a broad range of materials properties to 
the existing iodinated polymer platform described in Chapter 1.  For example, the thermal, 
mechanical, and x-ray properties of these copolymers could be fine-tuned by varying the amount 
of the iodinated component incorporated into the polymer.  These copolymers were also 
noncytotoxic and stable, showing long-lasting radiopacity.  Furthermore, these copolymers were 
tested as “smart” radiopaque biomaterials capable of performing the shape memory cycle several 
times.   
3.2 Experimental Methods 
3.2.1 Materials 
All materials were purchased from Sigma-Aldrich, Fisher Scientific, or VWR 
International and used as received.  Dichloromethane (CH2Cl2) was dried over CaH2 and distilled 
immediately before use.  2,2-Bis(iodomethyl)-1,3-propanediol was synthesized as described in 
Chapter 2, Section 2.2. 
3.2.2 General Characterization 
The polymers were characterized using a Bruker 400 AVANCE (1H NMR), a TA 
Instruments Q200 differential scanning calorimeter (DSC), and a Perkin Elmer Pyris 1 
thermogravimetric analyzer (TGA).  Gel permeation chromatography (GPC) was performed 
using a Waters 2695 separations module using THF as the mobile phase (1 mL min-1, 25 °C) 
with a Waters 2414 refractive index detector.  Average molar mass was derived from a 
calibration curve based on a series of PS standards ranging from 500 to 100,000 g mol-1.  
Thermosets were characterized by DSC, TGA, and dynamic mechanical analysis (DMA) on a 
TA Instruments G2 RSA.  Elemental analysis was performed using an Oxford instruments, 
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INCA PentaFET energy dispersive x-ray spectrometer (EDS) on a Hitachi S-4700 cold cathode 
field emission scanning electron microscope (SEM) and a Kratos Axis Ultra DLD X--ray 
Photoelectron Spectrometer (XPS).  CT images were performed using a Gamma Medica, Inc. 
eXplore CT-120 (70 kVp, 50 mA). 
3.2.3 Synthesis of poly(2,2-bis(iodomethyl)-1,3-propanediol-co-1,8-octanediol adipate) 
Various polymers were prepared via the polycondensation of 2,2-bis(iodomethyl)-1,3-
propanediol, 1,8-octanediol, and adipic acid.  The polymers were varied by modifying the ratio 
of the diol comonomers.  Section 3.2.3.a describes the typical polymerization method used to 
synthesize all of the polymers. 
3.2.3.a Polymer containing 15 mole percent 2,2-bis(iodomethyl)-1,3-propanediol (15%I) 
A dry flask was charged with 2,2-bis(iodomethyl)-1,3-propanediol (0.76 g, 2.14 mmol), 
1,8-octanediol (1.77 g, 12.12 mmol), adipic acid (2.00 g, 13.69 mmol), and scandium triflate 
(0.14 g, 0.28 mmol).  The flask was nitrogen purged before heating the reaction to 80 °C.  After 
5 hours, vacuum was applied and reduced to 0.3 torr at a rate of 80 torr per hour. This pressure 
was maintained for 24 hours.  The polymerization was terminated by cooling the reaction 
mixture to room temperature, dissolving the polymer in CHCl3, and precipitating the polymer 
into cold diethyl ether (-78 °C).  1H NMR, CDCl3, δ (ppm) 4.06 (m, 1.00H), 3.63 (t, 0.01H), 3.56 
(d, 0.03H), 3.26 (m, 0.11H), 2.32 (m, 1.03H), 1.63 (m, 2.17H), 1.32 (s, 1.87H).  
3.2.3.b Polymer containing 20 mole percent 2,2-bis(iodomethyl)-1,3-propanediol (20%I) 
1H NMR, CDCl3, δ (ppm) 4.08 (m, 1.00H), 3.66 (t, 0.02H), 3.58 (d, 0.03H), 3.29 (m, 
0.16H), 2.35 (m, 1.00H), 1.68 (m, 2.14H), 1.34 (s, 1.82H).  
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3.2.3.c Polymer containing 25 mole percent 2,2-bis(iodomethyl)-1,3-propanediol (25%I) 
1H NMR, CDCl3, δ (ppm) 4.06 (m, 1.00H), 3.63 (t, 0.01H), 3.56 (s, 0.03H), 3.27 (m, 
0.23H), 2.34 (m, 1.03H), 1.61 (m, 2.15H), 1.32 (s, 1.64H).  
3.2.3.d Polymer containing 35 mole percent 2,2-bis(iodomethyl)-1,3-propanediol (35%I) 
1H NMR, CDCl3, δ (ppm) 4.07 (m, 1.00H), 3.56 (d, 0.05H), 3.27 (m, 0.31H), 2.34 (m, 
1.06H), 1.64 (m, 2.03H), 1.32 (s, 1.47H).  
3.2.4 End-capping poly(2,2-bis(iodomethyl)-1,3-propanediol-co-1,8-octanediol adipate) with 
2-Isocyanatoethyl Methacrylate 
 
In a typical reaction, a dry round bottom flask was charged with the iodinated polymer 
(2.93 g, 0.42 mmol), and purged with nitrogen before the addition of dry CH2Cl2 (18 mL).  2-
Isocyanatoethyl methacrylate (0.25 mL, 1.76 mmol) was added, followed by the dropwise 
addition of tin(II) ethylhexanoate (40 µL, 0.11 mmol).  The reaction was stirred for 48 hours at 
room temperature.  The reaction was terminated by precipitation into cold diethyl ether (-78 °C). 
The prepolymer was dried in vacuo at room temperature for 24 hours before use and stored at     
4 °C. 
3.2.5 Thermoset Fabrication 
A prepolymer solution (2 g mL-1 in chloroform) containing approximately 2% b.w. 
diethoxyacetophenone was cast into a mold or onto a glass slide. The mold was then placed in a 
UV chamber (ELC-500 Light Exposure System) for 10 minutes under a flow of N2. The film was 
placed in a vacuum oven at 70 °C for 24 hours under high vacuum. 
3.2.6 Thermoset Cytotoxicity 
To assess the biocompatibility of the crosslinked films, 20,000 HeLa cells (human 
epithelial cervical adenocarcinoma cell line, ATCC CCL-2) were seeded into 24 well plates in 
1mL of complete MEM (1X) containing [L-glutamine (.292 g L-1) and 10% fetal bovine serum] 
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per well.  Cells were allowed to adhere for 24 hours and subsequently incubated with 1, 2, or 3 
pieces of crosslinked films (measured to be 0.75 cm in length, 2 mm high, and 2 mm wide) that 
were placed into Falcon cell culture inserts containing a 3 µm pore size.  One milliliter of 
complete medium was added to each insert and cells/crosslinked films were incubated for an 
additional 72 hours in a 37°C, 5% CO2 incubator.  After the 72-hour incubation period, cell 
culture inserts were removed and all medium was aspirated off cells. 300 µL of fresh medium 
was added back to each well followed by the addition of 300 µL CellTiter-Glo® Luminescent 
Cell Viability Assay reagent (Promega, Madison WI).  Plates were placed on a microplate shaker 
for 2 minutes, incubated at RT for 10 minutes to stabilize luminescent signal.  The luminescent 
signal was recorded on a Molecular Dynamics SpectraMax M5 plate reader.  Cell viability was 
expressed as a percentage of the luminescent signal of cells grown in the absence of crosslinked 
film (cells only in complete medium). 
3.2.7 Preliminary Thermoset Degradation by Hydrolysis 
Films of known weight were placed in 1 mL of 10 mM pH 7.4 phosphate buffered saline 
(PBS) solution at 37 °C.  The films were removed from the buffer solution at prescribed intervals 
and dried under vacuum for 72 hours before their masses were measured. Each measurement was 
performed on three separate samples.  Mass loss (ML) was calculated according to equation 2.1. 
3.2.8 Dynamic Mechanical Analysis and Shape Memory Testing 
An RSA-G2 dynamic mechanical analyzer from TA Instruments was employed for both 
shape programming and mechanical tests.  A typical temperature ramp ranged from 0 to 60 °C at 
the same heating and cooling rates of 3 °C min-1, where E is the tensile storage modulus 
measured by DMA at strain of 0.1% and a frequency of 1 Hz.  E was analyzed at 25 °C.  For 
shape programming, the sample was heated to 70 °C.  The sample was then stretched to a strain 
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of approximately 20% of the initial length.  After stretching, the sample was quenched at 0 °C 
and annealed at 0 °C for 5 minutes.  The instrument was then set to isoforce mode, where the 
external force was set to be constantly at zero as the sample was heated back to 70 °C.  Percent 
fixity (Rf) and percent recovery (Rr) were calculated (equations 1.3 and 1.4, Chapter 1). 
3.3 Results and Discussion 
3.3.1 Polymer Synthesis and Evaluation 
3.3.1.a Prepolymer Synthesis 
Because radiopaque shape memory materials were desired, semicrystallinity was an 
essential property.  Crystallites act as physical net-points, which hold the temporary shape in 
place.3,30  Because the bulky, iodinated units of 2,2-bis(iodomethyl)-1,3-propanediol produced 
100% amorphous homopolymers, a linear comonomer, 1,8-octanediol, was selected to induce 
semicrystallinity into the copolymers.  Scheme 3.1 displays the polymerization of poly(2,2-
bis(iodomethyl)-1,3-propanediol-co-1,8-octanediol adipate).  Four different copolymers were 
made by varying the ratio of 1,8-octanediol to 2,2-bis(iodomethyl)-1,3-propanediol.  The iodine 
content of the polymers was varied by targeting the incorporation of 15%, 20%, 25%, and 35% 
2,2-bis(iodomethyl)-1,3-propanediol by mole into the respective polymers.  For convenience, 
these iodinated copolymers will be identified by the targeted mole percent of 2,2-
bis(iodomethyl)-1,3-propanediol incorporated into the polymer; i.e., 15%I will represent the 
polymer with 15 mole percent of the iodinated monomer incorporated, as seen in the 
experimental section (Section 3.2.3).   
Overall, the synthesis of the copolymers was similar to the method used for the iodinated 
homopolymers described in Chapter 2 (Scheme 2.2).  A much lower reaction temperature was 
required in the synthesis of the copolymers as compared to the synthesis of the homopolymers 
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found in Chapter 2.  To synthesize the iodinated homopolymers, the reaction temperature started 
at 135 °C in order to melt 2,2-bis(iodomethyl)-1,3-propanediol, a crystalline solid (Tm ~130 °C; 
Appendix B, Table B1 and Figure B1).  The reaction temperature could only be lowered once 
oligomers formed.  In the synthesis of the copolymers (Scheme 3.1), the reaction temperature 
was maintained at 80 °C throughout the course of the synthesis.  At 80 °C, 1,8-octanediol is a 
liquid capable of solubilizing the iodinated diol. 
    
 
Scheme 3.1 Synthesis of iodinated copolymers followed by photo-crosslinking to yield iodinated 
thermosets. 
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The copolymers ranged from 5,500 to 7,700 g mol-1 with dispersities of approximately 
1.3 (Đ lower than 2 is due to fractionation upon purification; Table 3.1).  The iodine content was 
calculated by 1H NMR and compared to the targeted mole percent of the iodinated monomer 
(Table 3.1).  Peaks associated with the iodinated monomer were compared with peaks associated 
with the diacid unit (Appendix B, Figures B3-B6).  On average, the polymers incorporated 83% 
of the intended mole percent of the iodinated monomer.   
The Tm of the iodinated prepolymers increased as the amount of 1,8-octanediol increased, 
from 40 to 58 °C.  A Tm slightly greater than 37 °C (body temperature) was desired.  The glass 
transition temperatures increased with decreasing amounts of 1,8-octanediol.  While this trend 
may seem counterintuitive, the trend in Tg is believed to be due to the higher amount of iodinated 
monomer, which raises the specific volume of the polymer.  The bulky iodinated monomer is 
believed to increase the energy barrier for bond rotation, thus making the Tg increase slightly.31  
At 35%I, the ratio Tg/Tm (Kelvin temperatures) is exactly 0.75, thus this polymer is asymmetric, 
and the Tg is dependent on secondary forces and chain mobility (i.e., bond rotation).32  This Tg 
dependence on iodinated monomer content was also observed in the homopolymers in Chapter 2. 
The thermal degradation temperatures of these materials matched the expected degradation 
temperatures of typical aliphatic polyesters.33 
 
Table 3.1 Iodinated Copolymer Properties. 
 
 
a Measured by 1H NMR (400 MHz in CDCl3). b Measured by GPC in THF using polystyrene 
standards.  c Measured by TGA.  d Measured by DSC, mid-point of the second heat. 
Polymer  
(by mol %I) 
Mn 
(g mol-1)a 
Actual mol %I 
monomera 
<Mn> 
(g mol-1)b 
<Mw> 
(g mol-1)b Đ
b Tg (°C)c 
Tm 
(°C)c 
5% 
(°C)d 
15 7000 11 11000 15000 1.3 -46 58 340 
20 5600 16 9000 12000 1.3 -44 54 341 
25 7700 23 10000 13000 1.3 -40 48 341 
35 5500 31 9800 12000 1.2 -37 40 368 
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3.3.1.b Iodinated Copolymer Thermosets 
 Next, the polymers were endcapped with 2-isocyanatoethyl methacrylate, which formed 
macromonomers and allowed facile UV crosslinking.  To crosslink the prepolymers into 
thermosets, a 1:1 (b.w.) mixture of prepolymer and chloroform was made followed by the 
addition of a photoinitiator, diethoxyacetophenone.  The mixture was added to a mold and 
exposed to UV light for 10 minutes under a flow of nitrogen.  Chemical crosslinks were 
incorporated into the polymer network to hold the polymer in its permanent shape (i.e., 
permanent net-points).3,30   
The mechanical and thermal properties of the resulting thermosets varied depending on 
the ratio of comonomer diols (Table 3.2 and Figure 3.1).  The 20%I polymer had a Tm of 41 °C, 
which was ideal, as it would allow local heating without damaging the surrounding cells in an in 
vivo implantable biomaterial application.34  Increasing the percentage of iodinated monomer 
resulted in a decrease of the Tm and the storage modulus (E) because the polymer was less 
crystalline (Table 3.2 and Figure 3.1).  The storage moduli of the materials varied from 16 to 143 
MPa as the amount of crystalline monomer increased.  
 
Table 3.2 Iodinated Copolymer Thermoset Properties. 
Polymer film 
(by mol%I) Tg (°C)
a Tm (°C)a 5% (°C)b E (MPa)c 
15 -47 47 397 143 
20 -45 41 362 66 
25 -42 34 382 34 
35 -37 33 383 16 
 
a DSC, second heat 10 °C min-1, b Decomposition measured by TGA 20 °C min-1, c DMA tensile 
storage modulus at T = 25 °C. 
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Figure 3.1 The melting temperature found by DSC and storage modulus at 25 °C using DMA for 
each crosslinked copolymer film. 
	
 The impact of UV crosslinking on iodine content was studied by determining the weight 
percent of iodine in the prepolymers and in the thermosets using EDS.  Figure 3.2 shows that the 
UV crosslinking process had little to no effect on iodine content, an indication of UV stability 
(Tables B3-B11, Appendix B).  Figure B21 in Appendix B also shows that the films had minimal 
color change as a result of UV exposure, which is indicative of minimal iodine loss.18,35  Minimal 
color change is significant, as traditional inorganic radiopaque agents and radiocontrast-inducing 
additives can cause undesirable discoloration.18 
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Figure 3.2 EDS of the iodinated prepolymers and crosslinked thermosets. 
 
3.3.2 Thermoset Cytotoxicity 
The cytotoxicity of the iodinated copolymers was analyzed by measuring the percent 
viability of HeLa cells after 3 days of incubation (Figure 3.3).  Each experiment was performed 
on 1, 2, and 3 spacers (dimensions of 0.75 x 2 x 2 mm) to examine how the size of the sample 
affected cell viability.  Almost all of the thermosets showed no cytotoxicity (cell viability ³80%).  
The sample containing three spacers of the 35%I polymer showed cytotoxicity with only 48% 
cell viability, thus suggesting increased iodine content (by %I and film amount) leads to 
cytotoxicity. 
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Figure 3.3 Cytotoxicity of the crosslinked thermosets after 3 days of incubation examining the 
effect of sample size (1-3 spacers) on cell viability. 
	
3.3.3 Thermoset Radiopacity 
 The radiopacity of the polymers was studied by CT imaging.  Figure 3.4A shows CT 
images of the iodinated thermosets.  The high radiocontrast of all of the thermosets was apparent 
when comparing the CT images to aluminum and polycaprolactone (PCL; Figure 3.4).  Figure 
3.4A also shows that the radiopacity of the iodinated thermosets are homogenous throughout the 
entire polymer film.  Figure 3.4B displays the attenuation of the aluminum bar, iodinated 
thermosets, and PCL in attenuation units calculated using ImageJ software.  Figure 3.4B clearly 
shows that the radiopacity of the iodinated thermosets is dependent on iodine content, as the 
attenuation decreases with decreasing mole percent of the iodinated monomer.  Figure 3.4 also 
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shows the lack of radiocontrast of typical biomaterials, such as PCL (Figure 3.4 F), due to their 
lack of high Z elements.  
 
Figure 3.4 A) CT images of an aluminum bar (A), the iodinated thermosets from 35%I to 15%I 
(B, C, D, E, respectively), and PCL (F).  B) Attenuation units of the iodinated thermosets 
compared to aluminum and PCL. 
	
3.3.3.a Long-term Radiopacity 
The thermosets were placed in a PBS solution at 37 °C, removed from the buffer solution 
at prescribed intervals, and dried under vacuum before further analysis.  A CT image was taken 
at the four-week mark (Figure 3.5), depicting the long-lasting radiopacity of the films.  The high 
cell viability displayed in Figure 3.3 along with the radiocontrast shown in Figure 3.5 indicates 
minimal leaching of any cytotoxic or radiopaque molecules.  The radiocontrast of the thermosets 
after four weeks of incubation also suggests that any polymer degradation occurred at the ester 
linkages of the copolymers and was not due to side reactions that would result in a loss of iodine. 
Table 3.3 displays the mass loss of each sample over the four-week incubation period 
(PBS, 37 °C).  The high iodine content of these materials makes them very hydrophobic and 
increases the steric hindrance of water molecules to the ester linkages.36  Furthermore, chemical 
crosslinks and crystallinity can limit water penetration and hydrolytic degradation.37–40  Thus, the 
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polymers showed low mass losses, between 0.7-5.2%.  Typical degradable polymers and 
elastomers can take 6 months to 3 years to degrade;37–42 therefore, further degradation studies 
must be carried out to confirm that the mass loss measured in Table 3.3 was due to polymer 
degradation rather than leaching of small molecules or oligomers.  Rapidly degradable polymers 
could be built by incorporating comonomers or copolymers, such as 3,3'-dithiodipropionic acid 
or PEG. 
 
 
Figure 3.5 Week 4 CT image of the thermosets that were incubated in PBS buffer solution at    
37 °C. 
 
Table 3.3 Mass Loss of Crosslinked Films After 4 Weeks at 37 °C in PBS Buffer Solution. 
Polymer film 
(by mol% I monomer) 
Mass loss at  
4 weeks (%) 
15 4.5 ±0.7 
20 2.1 ±0.3 
25 1.6 ±0.9 
35 4.2 ±0.7 
 
3.3.4 Shape Memory 
Crosslinking the polymers provided the net-points needed to maintain the polymers’ 
permanent shape during the shape memory cycle.  In order to test the shape memory cycle on the 
iodinated copolymers, DMA was performed.  Figure 3.6 shows the third shape memory cycle for 
each sample, where “1” represents the sample in its initial, permanent shape.  At 1, the sample 
was heated above its Tm to 70 °C.  From 1 to 2, the sample was stretched to a strain 
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approximately 20% higher than the initial length.  In the process of going from 2 to 3, the sample 
was quenched at 0 °C.  At 3, the sample was annealed at 0 °C for 5 minutes to allow crystallites 
to form and act as physical net-points that hold the secondary shape in-place.  The transition 
from 3 to 4 was the result of relaxation that occurred when the instrument was set to maintain an 
external force of zero.  Finally, 4 to 1 represents the process of reheating the sample and 
inducing shape change back to the original shape as the polymer exceeds the melting 
temperature.3,43  The percent fixity (Rf) and percent recovery (Rr) were calculated using 
equations 1.3 and 1.4 (Table 3.4).  High values of both fixity and recovery were observed for all 
of the polymers.  The highest values were observed in samples that were more crystalline. 
 
Figure 3.6 Third shape-memory cycle for each crosslinked copolymer.  Step 1:  The polymer is 
heated and mechanically deformed into its temporary position. Step 2:  The polymer is cooled 
below its transition temperature under a constant mechanical stress.  Step 3:  The polymer is 
unloaded, releasing the applied stress.  Step 4:  The polymer is heated past its transition 
temperature and returns to its permanent shape. 
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Table 3.4 Strain Fixity and Recovery Over Three Shape Memory Cycles. 
Polymer film 
(by mol%I) 
R
f 
(%) R
r
 (%) 
15 99.8 ±0.2 99.8 ±0.2 
20 99.6 ±0.7 99.6 ±0.7 
25 89.7 ±1.6 89.8 ±1.3 
35 87.2 ±2.1 87.2 ±2.1 
 
3.4 Conclusions 
A series of iodinated copolyesters were synthesized and evaluated.  By incorporating a 
linear comonomer diol, 1,8-octanediol, with the signature iodinated diol, 2,2-bis(iodomethyl)-
1,3-propanediol, semicrystalline polymers were developed.  These polymers were end-
functionalized with a photo-crosslinkable methacrylate unit for easy fabrication of thermosets, 
and the thermosets maintained high iodine contents after UV exposure.   
The resulting prepolymers and thermosets had tunable thermal, mechanical, and x-ray 
capabilities.  By modifying the ratio of 1,8-octanediol to 2,2-bis(iodomethyl)-1,3-propanediol, 
the crystallinity and iodine content of the polymers was altered; this allowed for the design of a 
polymer with an ideal Tm of 41 °C (just above body temperature) and high radiocontrast.  
Regardless of the iodine content, all of the polymers were highly radiopaque, which was 
beneficial, as increasing iodine content and sample amount led to lower percent cell viability and 
shape memory capability.  The polymers of 15%I, 20%I, and 25%I showed no cytotoxicity 
regardless of sample size.  All of the polymers showed high, long-lasting radiopacity.   
Additionally, these polymers possessed “smart”, shape memory capabilities.  For 
example, the 20%I polymer not only had an ideal Tm, but also showed Rr and Rf values of >99%.  
The work presented here further illustrates the versatility of the iodinated polymer platform 
outlined in Chapter 1.  This copolymer platform not only exhibits the properties outlined in 
	 79 
Chapter 1:  modular physical and chemical properties, high radiopacity, low cost, easy 
processability, and sound biocompatibility; but also, this platform has the added benefit of 
“smart” actuation via the thermal shape memory process.  Thus, these materials serve as the first 
example of an inherently radiopaque, aliphatic shape memory polymer with nontoxic, stable, 
covalently attached iodine.  
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CHAPTER 4: SUPRAMOLECULAR ENGINEERING POLYESTERS:  ENDGROUP 
FUNCTIONALIZATION OF GLYCOL MODIFIED PET WITH UREIDOPYRIMIDINONE 
 
4.1 Introduction 
Modification of polymer properties through post-polymerization functionalization is of 
significant interest, specifically through the use of supramolecular chemistry.1–4  
Functionalization of polymer endgroups with supramolecular units (e.g. hydrogen bonding units) 
results in noncovalent bonds that dramatically alter the properties of the initial polymer.5–9  In 
particular, terminal functionalization using the quadruple hydrogen bonding ureidopyrimidinone 
(UPy) group produces superior, thermally reversible polymer assemblies that merge orthogonal 
properties, such as low melt viscosity and enhanced elasticity.7,8  The UPy motif has been 
extensively applied to low molecular weight, aliphatic polymers.  Systems including PEO/PPO,5 
PDMS,10 PEB,6–8 polyTHF,9,11 PCL,11–13 and aliphatic polycarbonates9,14 have been explored.  
Additionally, utilization of different linker units attaching the UPy endgroup to the virgin 
polymer have led to dramatic differences in fiber formation and stress-relaxation.8  
Thermoplastic elastomers,7,15 recyclable materials,16 adhesives,17 and bioactive scaffolds18 have 
been developed using UPy terminated, low-performing polymers.  These polymers generally 
have glass transition temperatures significantly lower than the reported dissociation temperature 
of UPy-UPy aggregates (approximately 80 °C).19  Hydrogen bonding moieties have also been 
applied to polymers with higher glass transition temperatures, such as polystyrene.20–22  
However, the UPy moiety has had limited investigation with more robust glassy or semi-
crystalline polymers.  The reversible bonding of UPy assemblies, and thus reversible decrease of 
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molecular weight, could be of great use if applied to high performance and engineering 
polymers.  
High performance and engineering polymers are often manufactured into shaped objects 
in the polymer melt state.23,24   Because these polymers are ubiquitous in everyday life, the 
design of engineering polymers with robust mechanical properties at room temperature and low 
viscosity at elevated temperatures is greatly desired.  The combination of these properties into 
one polymeric system is particularly challenging because processability is lost as performance is 
enhanced.23  A great deal of work has been dedicated to the development of easily processable 
engineering polymers through the synthesis of new monomers and polymerization of novel 
copolymers; however, this work is costly and arduous.23,25,26  The design of mechanically robust, 
highly processable engineering polymers via modification of existing polymers would be 
significant.  
The melt viscosity of low molecular weight engineering polymers is much lower than 
that of high molecular weight polymers; despite their excellent processability, the mechanical 
properties of these low molecular weight materials are greatly diminished due to a lack of 
entanglements.3,16  By utilizing thermally reversible, noncovalent bonds, the mechanical 
properties of low molecular weight engineering plastics could be improved at room temperature 
while maintaining their processability.  In a seminal study, Long and coworkers reported UPy 
functionalization of low molecular weight poly(butylene terephthalate) (PBT), an industrial 
engineering polymer.19  This material displayed high tensile strength and toughness.  The 
viscosity at 235 °C was more than ten times lower than the viscosity of high molecular weight 
PBT.  However, the processing temperature remained problematic, as the temperature at which 
these viscoelastic improvements were observed also approached the decomposition temperature 
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of the UPy end-unit (onset of weight loss at 200 °C).22,27  Furthermore, the improvement in 
viscosity was dependent on the inherent Tm of PBT (225 °C).  This study clearly revealed the 
importance of the thermal properties of the virgin material. 
Herein, the first example of a supramolecular engineering polymer with enhanced 
thermal and mechanical properties that also shows improved melt viscosity at temperatures well 
below the decomposition temperature of the UPy moiety is reported.  Glycol modified 
poly(ethylene terephthalate) (PETG) was carefully selected for end-functionalization due to its 
unique thermal properties.  High molecular weight PETG has a Tg of 80 °C; therefore, low 
molecular weight PETG displays glass transition temperatures below the UPy-UPy dissociation 
temperature.  Furthermore, incorporation of a cyclohexyl diol comonomer induces slow 
crystallization kinetics (halftime >1000 minutes), thus producing an amorphous copolyester.25  
The relationship between endgroup structure and polymer structure along with physical 
performance (thermal, mechanical, rheological) were investigated.  This system serves as 
evidence that the improvement of the thermal, mechanical, and melt-viscoelastic properties of an 
engineering polymer through endgroup modification with supramolecular binding units can be 
achieved.  The terminal functionalization of this class of engineering polyesters with various 
endgroup linkers, along with thorough characterization, deepens the current understanding of 
supramolecular chemistry with respect to robust polymer systems and demonstrates that 
supramolecular chemistry could be applied more broadly for the improvement of industrially 
relevant, high performing polymers. 
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4.2 Experimental Methods 
4.2.1 Materials 
PETG of various molecular weights, 2000, 3800, and 6800 g mol-1 (PETG2k, PETG3.8k, 
PETG6.8k) were provided by Eastman Chemical Company (molecular weight verified by inherent 
viscosity) and dried in vacuo at 50 °C for 24 hours before use.  2-Amino-4-hydroxy-6-
methylpyrimidine (MIS) (98%), hexamethylene diisocyanate (HDI) (³99%), and dibutyltin 
dilaurate (DBTDL) (95%) were used as received from Aldrich.  4,4′-Methylenebis(cyclohexyl 
isocyanate) (HDMI) (mixture of isomers, >97%) and 1,3-bis(isocyanatomethyl)cyclohexane (cis- 
and trans- mixture, >99%) were used as received from TCI America.  Pentanes, sand (sea 
washed), and silica gel were used as received from Fisher Scientific.  Chloroform (99.9%, 
stabilized with amylenes, extra dry) was purchased from Acros and filtered over a column of 
aluminum oxide (Brockmann I) and stored over molecular sieves.  1,2,4-Trichlorobenzene (99%) 
and pyridine (³99%) were purchased from Acros and dried over molecular sieves.  2(6-
Isocyanatohexylaminocarbonylamino)-6-methyl-4[1H]pyrimidinone (H-UPy) and all polymers 
functionalized with the H-UPy endgroup were synthesized as previously reported (PETG-H-
UPy).7 
4.2.2 Characterization 
4.2.2.a General Characterization  
1H NMR spectra were recorded on a Bruker 400 AVANCE (400 MHz) using CDCl3.  
Variable temperature 1H NMR spectra were recorded on a Bruker 500 AVANCE (500 MHz) 
using 1,1,2,2-tetrachloroethane-d2 (TCE-d2).  The temperature was calibrated using ethylene 
glycol, and a 600 s soak time was allowed at each temperature (25-100 °C).  Thermal properties 
were measured using a TA Instruments Q200 DSC (heating rate of 10 °C min-1) and a TA 
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Instruments Q5000 TGA (25-550 °C).  GPC was performed using a Waters 2695 separations 
module using chloroform as the mobile phase (1 mL min-1, 25 °C) with a Waters 2414 refractive 
index detector.  Average molar mass was derived from a calibration curve based on a series of 
PS standards ranging from 500 to 100,000 g mol-1.  ATR FT-IR spectra were recorded on a 
Bruker ALPHA or a Perkin-Elmer Spectrum II instrument with a diamond crystal ATR 
accessory.  
4.2.2.b Characterization of Melt-pressed Discs 
Rheological measurements were performed on a TA Instruments ARES-G2 rheometer 
using an 8 mm parallel plate fixture and 1000 µm gap.  Dynamic oscillatory shear measurements 
were used to calculate the G’, G” and tand at 1 Hz and 0.1% strain with temperatures from 160-
35 °C at a ramp rate of 3 °C min-1.  Samples were first heated to 160 °C (300 s soak), and then 
measured over both a cooling and a heating cycle.  Each measurement was performed on three 
samples, and the average curve was calculated using OriginPro software.  Frequency sweeps 
were measured from 1-600 rad s-1 (1 Hz, 0.1% strain) at 90 and 120 °C.  Viscosity was measured 
over temperatures from 160 °C to approximately 90 °C at 3 °C min-1 and 0.05 s-1 shear rate.  The 
lowest temperature was dependent on the amount of torque applied to the fixture as the material 
approached its Tg.  The materials of 2000 g mol-1 were only heated to 140 °C due to their low 
viscosities.  Each measurement was performed on three samples, and the average curve was 
calculated using OriginPro software.  
4.2.2.c Characterization of Drop-cast Films 
 AFM was performed using an Asylum Research MFP3D Atomic Force Microscope in 
tapping mode at a scan rate of 1 Hz.  Tap300Al-G rotated monolithic silicon probes with 30 nm 
aluminum reflectivity coating, resonant frequency of 300 kHz, spring constant of 40 N m-1, 
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length of 125 µm, width of 30 µm, and nominal tip radius of curvature less than 10 nm were 
used.  Images were displayed and analyzed using Nanoscope 6.14R1 software. 
4.2.2.d Characterization of Solvent-cast Films 
 Tensile tests were performed on an Instron Model 5566 equipped with a 500 N load cell.  
The samples (3 mm strips) were extended at a rate of 10 mm min-1 at room temperature until 
failure.  Static water-in-air contact angles were measured with a KSV instrument and imaging 
using the goniometer/static sessile drop method (with at least 3 different spots on one film). 
4.2.3 Synthesis 
4.2.3.a Synthesis of 1-((3-(Isocyanatomethyl)cyclohexyl)methyl)-3-(6-methyl-4-oxo-1,4-
dihydropyrimidin-2-yl)urea (CH-UPy)  
  
 MIS (0.50 g, 3.99 mmol) was charged to a dry three-neck round-bottomed flask fitted 
with a reflux condenser.  1,3-Bis(isocyanatomethyl)cyclohexane (4.79 mL, 27.17 mmol) was 
charged, and the mixture was heated to 100 °C under nitrogen atmosphere.  After 24 hours, the 
reaction mixture was allowed to cool to room temperature, and then washed two times with 
pentanes to remove excess 1,3-bis(isocyanatomethyl)cyclohexane.  The product was dissolved in 
chloroform and precipitated into cold pentanes.  The white product was filtered and dried in 
vacuo at 40 °C overnight (yield 65%).  1H NMR (400 MHz, CDCl3) δ: 13.08 (N−H, 1H), 11.90 
(N−H, 1H), 10.23 (N−H, 1H), 5.82 (s, 1H), 3.15 (m, 4H), 2.23 (s, 3H), 1.95 (m, 1H), 1.81 (m, 
4H), 1.37 (m, 1H), 1.27 (m, 1H), 0.90 (m, 2H), 0.69 (q, 1H).  FT-IR (ATR): ν = 2920 cm-1 
(ureido N−H), 2259 cm−1 (−NCO), 1662 cm-1 (ureido C=O), 1521 (ureido N−H). 
4.2.3.b Synthesis of PETG2k Functionalized with CH-UPy (PETG2k-CH-UPy) 
PETG2k (2000 g mol-1, 1.68 g, 0.84 mmol), CH-UPy (0.80 g, 2.52 mmol), and 85 mL 
chloroform were charged to a dry round-bottomed flask equipped with a reflux condenser.  The 
reaction mixture was heated to 65 °C under nitrogen, and then DBTDL (0.20 mL, 0.34 mmol) 
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was added.  After 16 hours, 2 g silica gel was charged to the reaction mixture along with DBTDL 
(0.10 mL, 0.17 mmol), and the reaction stirred at 65 °C for 2 hours.  The hot solution was 
filtered over a short column of sand to remove the silica gel.  The chloroform was removed by 
rotary evaporation and the resulting polymer was dried in vacuo at 60 °C.  1H NMR (400 MHz, 
CDCl3) δ: 13.10 (N−H, 0.02H), 11.84 (N−H, 0.02H), 10.17 (N−H, 0.02H), 8.12 (s, 1H), 5.83 (s, 
0.02H), 4.72 (s, 0.57H), 4.53 (s, 0.09H), 4.41 (s, 0.08H), 4.31 (d, 0.12H), 4.21 (d, 0.24H), 4.00 
(s, 0.02H), 3.90 (s, 0.04H), 3.24 (m, 0.03H), 3.08 (d, 0.14H), 2.23 (s, 0.10H), 1.96 (q, 0.53H), 
1.68 (m, 0.18H), 1.27 (s, 0.16H), 1.18 (m, 0.26H), 0.88 (m, 0.11H), 0.63 (m, 0.04H).  FT-IR 
(ATR): ν = 1715 cm-1 (PETG C=O), 1662 cm-1 (ureido C=O), 1521 (ureido N−H). 
4.2.3.c Synthesis of Ureidopyrimidinone Functionalized PETG2k with Dicyclohexyl Linker 
(PETG2k-D-UPy) 
 
HDMI (0.46 mL, 1.9 mmol), chloroform (5 mL), and DBTDL (0.20 mL, 0.34 mmol) 
were charged to a dry three-neck round-bottomed flask.  In a separate, dry flask, a solution of 
PETG2k (2000 g mol-1, 1.5 g, 0.75 mmol) in chloroform (10 mL) was prepared.  The PETG2k 
solution was added to the HDMI solution dropwise using an addition funnel.  The reaction 
mixture stirred under nitrogen at room temperature for 24 hours, and then the chloroform was 
removed by rotary evaporation.  Pyridine (10 mL) was charged to reaction flask followed by 
MIS (0.70 g, 5.6 mmol) and DBTDL (0.20 mL, 0.34 mmol).  A reflux condenser was fit to the 
flask, and the reaction stirred at 120 °C under nitrogen for 24 hours.  Pyridine was removed by 
rotary evaporation, and then the crude product was dissolved in chloroform.  Excess MIS was 
filtered, and the chloroform was removed by rotary evaporation.  The resulting polymer was 
dried in vacuo at 60 °C.  1H NMR (400 MHz, CDCl3) δ:  13.13 (N−H, 0.02H), 11.93 (N−H, 
0.02H), 9.80 (N−H, 0.02H), 8.10 (s, 1H), 5.81 (s, 0.02H), 4.68 (s, 0.58H), 4.49 (s, 0.14H), 4.39 
(d, 0.09H), 4.28 (d, 0.11H), 4.18 (s, 0.26H), 3.98 (s, 0.01H), 3.87 (s, 0.03H), 3.77 (s, 0.07H), 
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3.40 (s, 0.06H), 2.34 (s, 0.01H), 2.20 (s, 0.08H), 1.95 (q, 0.53H), 1.63 (m, 0.88H), 1.13 (s, 1.4H).  
FT-IR (ATR): ν = 1715 cm-1 (PETG C=O), 1660 cm-1 (ureido C=O), 1523 (ureido N−H). 
4.2.4 Sample Fabrication 
4.2.4.a Melt-Pressed Discs 
Discs were made using a hydraulic melt press at 180 °C using specially made shims of 1 
mm thickness and 8 mm diameter.  The samples were allowed to fully melt without pressure for 
1-3 minutes, and then 10-15 tons of pressure was applied for 3-4 minutes. 
4.2.4.b Drop-cast Films 
 Polymer solutions were prepared in 1,2,4-trichlorobenzene (1.0 mg mL-1 at approximately 
120 °C).  The solutions were drop-cast onto dry, clean glass slides (cleaned with chloroform and 
ethanol) using a pipette, and then placed in an oven at 120 °C overnight. 
4.2.4.c Solvent-cast Films 
 Solvent-cast films were prepared for tensile testing using a micrometer-based doctor-
blade.  PETG solutions of 25% w/w and PETG-H-UPy solutions of 13% w/w were prepared in 
1,2,4-trichlorobenzene at 120 °C.  These concentrations produced suitable solution viscosities for 
fabricating uniform films, noting that the UPy functionalized polymers required a lower 
concentration due to the increased viscosity of the UPy-UPy aggregated polymers.  The solvent 
evaporated at 120 °C for 16 hours at ambient pressure, and then the films dried under vacuum for 
3 hours, gradually increasing the temperature to 180 °C.  The films had an average thickness of 
40 µm.  
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4.3 Results and Discussion 
4.3.1 Synthesis and Characterization of UPy Functionalized PETG  
4.3.1.a UPy Functionalization Using Multiple Linkers   
The packing capability of UPy endgroups could be affected by the structure of the linker, 
which attaches the UPy moiety to the polymer terminus.5  Therefore, three endgroup linkers of 
increasing rigidity were investigated, as depicted in Scheme 4.1.  The preparation of PETG2k-H-
UPy7 and PETG2k-CH-UPy involved separate synthesis of the respective endgroups (Scheme 
4.2) followed by functionalization of hydroxyl terminated PETG.  While similar approaches 
were attempted in the synthesis of PETG2k-D-UPy without success, a one-pot synthetic route 
(Scheme 4.3) was utilized to successfully make the polymer.5,22  
 
 
 
Scheme 4.1 UPy functionalized PETG of 2000 g mol-1 utilizing either a hexamethylene (H), 
cyclohexyl (CH), or dicyclohexyl (D) linker unit (R). 
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Scheme 4.2 Endgroup synthesis utilizing different diisocyanates. 
	
	
 
Scheme 4.3 One-pot synthesis of UPy functionalized PETG of 2000 g mol-1 utilizing a 
dicyclohexyl linker group. 
 
 Table 4.1 summarizes the molecular weight, molecular weight distribution, and thermal 
properties of the resulting polymers.  The number average molecular weight obtained by GPC 
was similar before and after end-functionalization.  UPy functionalization caused a slight 
increase in the overall molecular weight (decreased retention times) of the polymers.  Similar 
increases in molecular weight were observed when comparing PETG2k-H-UPy, PETG2k-CH-UPy 
and PETG2k-D-UPy, suggesting minimal chain extension occurred during the one-pot synthesis 
of PETG2k-D-UPy.  Endgroup analysis, calculated by 1H NMR, also confirmed that the degree of 
polymerization (Xn) did not appreciably change during the synthesis of PETG2k-D-UPy.  The 
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relative integrals associated with the aromatic protons of the repeating unit at 8.10 ppm and the 
methylene group of the hydroxyl endgroup at 3.98 ppm was similar to the ratio of the integral 
associated with the repeating unit and the same methylene group after UPy functionalization, 
which caused a downfield shift to 4.40 ppm (Figures C3 and C4, Appendix C).  The 1H NMR 
spectra used to determine Xn of PETG2k-CH-UPy and PETG2k-H-UPy are shown in the 
Appendix C (Figures C5 and C6, respectively). 
 
Table 4.1 Properties of PETG and UPy Functionalized PETG of 2000 g mol-1. 
Sample <Mn>a <Mw>a Đa 5% Degradationb Tgc 
 (g mol-1) (g mol-1)  (°C) (°C) 
PETG2k 2600 3900 1.5 378 46 
PETG2k-H-UPy 3600 5900 1.6 336 67 
PETG2k-CH-UPy 5500 10000 1.9 269 66 
PETG2k-D-UPy 5200 10000 2.0 247 61 
 
 aMeasured by GPC in CHCl3 using polystyrene standards.  b Measured by TGA.  c Measured by 
DSC, mid-point of the second heat. 
 
 
 Table 4.1 also shows the temperature of degradation was analyzed by thermogravimetric 
analysis.  As expected, the UPy functionalized polymers displayed lower degradation 
temperatures (5% b.w. at 247-336 °C) as compared to PETG2k (5% b.w. at 378 °C) due to 
decomposition of the isocytosine head.27  End-functionalization with the UPy moiety caused an 
increase in the Tg as compared with the unfunctionalized PETG, suggesting strong interactions 
among the quadruple hydrogen bonding endgroups.  Thus, supramolecular self-assembly of the 
UPy endgroups led to an increase in the “operative” molecular weight and Tg of the polymers. 
4.3.1.b H-UPy Functionalized PETG of Various Molecular Weights 
Full thermal, mechanical, and rheological characterization of PETG of various molecular 
weights before and after end-functionalization would allow for a thorough study of the effects of 
the UPy moiety attached to engineering polymers.  Due to the ease of synthesis and the fact that 
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H-UPy functionalization caused the most pronounced increase in Tg, PETG of various molecular 
weights were functionalized with H-UPy.  The critical molecular weight for entanglements 
(CME) of PETG is approximately 5000 g mol-1; therefore, molecular weights just below and 
above the CME, 3800 and 6800 g mol-1 (as calculated by inherent viscosity), were selected.  The 
molecular weight, molecular weight distribution, and thermal properties of the higher molecular 
weight polymers before and after H-UPy functionalization can be found in Table 4.2. GPC and 
endgroup analysis by 1H NMR confirmed that the molecular weight and Xn did not appreciably 
change due to end-functionalization (Table 4.2 and Figures C7-C10, Appendix C, respectively).  
Furthermore, decreases in the degradation temperatures of the H-UPy functionalized polymers 
were observed.  Analogous to the TGA results displayed in Table 4.1, the lower degradation 
temperatures found in Table 4.2 are due to early decomposition of the isocytosine head of the 
UPy end-unit.  
 
Table 4.2 Properties of PETG and H-UPy Functionalized PETG of 3800 and 6800 g mol-1. 
Sample <Mn>a <Mw>a Đa 5% Degradationb Tgc 
 (g mol-1) (g mol-1)  (°C) (°C) 
PETG3.8k 6100 10000 1.7 387 58 
PETG3.8k-H-UPy 10000 16000 1.6 360 71 
PETG6.8k 12000 21000 1.8 381 72 
PETG6.8k-H-UPy 17000 27000 1.6 371 72 
 
a Measured by GPC in CHCl3 using polystyrene standards.  b Measured by TGA.  c Measured by 
DSC, mid-point of the second heat. 
 
 
4.3.2 Thermal, Mechanical, and Viscoelastic Properties of PETG-H-UPy of Various 
Molecular Weights 
 
4.3.2.a Thermal Characterization 
 Figure 4.1A displays the thermal properties of the raw polymer powders with no further 
processing performed after synthesis.  The Tg of PETG2k-H-UPy was 21 °C higher than the Tg of 
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PETG2k; whereas, the Tg of PETG3.8k-H-UPy was only 13 °C higher than the Tg of PETG3.8k.  If 
the UPy endgroups of PETG2k-H-UPy aggregated as a simple dimer, the Tg would be expected to 
be similar to the Tg of PETG3.8k, which is approximately twice its molecular weight.  However, 
the Tg of PETG2k-H-UPy was approximately 10 °C higher than the Tg of PETG3.8k.  The 
relationship between molecular weight and Tg therefore suggests that the UPy endgroups 
aggregate in a multiple fashion in the melt state (through either multiple end-to-end interactions 
or pi-pi stacking) when the molecular weight is below the CME.22  There was no difference in Tg 
before and after H-UPy functionalization when looking at the polymers of 6800 g mol-1 (Figure 
4.1A).  This result was not surprising, since the polymers are above the CME.  Also, because 
PETG6.8k-H-UPy is of higher molecular weight than PETG2k-H-UPy and PETG3.8k-H-UPy, it has 
fewer endgroups and a lower concentration of UPy end-units. 
 
	
Figure 4.1 DSC spectra (second heating cycle, 10 °C min-1) of PETG and PETG functionalized 
with H-UPy A) directly after synthesis, and B) after melt processing. 
 
Polymer processing can have a significant impact on properties.  Furthermore, the 
importance of thermal annealing in UPy functionalized systems is well documented.15,16,28 The 
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polymers were melt-pressed into 8 mm diameter circular discs for rheological experiments, and 
thermal properties were analyzed by DSC after melt processing.  Figure 4.1B depicts the DSC 
spectra of the samples after melt processing.  The UPy functionalized polymers revealed more 
dramatic increases in Tg as compared with the unfunctionalized polymers of the same molecular 
weight, suggesting that melt processing enhanced UPy aggregation.  Importantly, the Tg (by 
DSC) of high molecular weight, commercial- grade PETG is approximately 80 °C, very close to 
the Tg of each of the melt processed UPy functionalized polymers.  Regardless of base molecular 
weight, UPy aggregation increased the “operative” molecular weight of the polymers to well 
above the CME.   
 Because the increase in Tg of the unfunctionalized materials was not significant, 
transesterification was not suspected.  GPC was performed on the UPy functionalized polymers 
after processing to ensure Tg increases were due to annealing alone (Figure 4.2).  ATR FT-IR as 
well as 1H NMR were also used to analyze the polymers before and after processing (Figures 
C19-C27, Appendix C).  This not only eliminated concerns of transesterification but also 
crosslinking of the urea or urethane linkages into biuret or allophanate units.29  
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Figure 4.2 GPC traces A) of the raw powder run directly after synthesis, and B) of the melt-
pressed materials (CHCl3 at 25 °C and 1.0 mL min-1 using polystyrene standards). 
 Dynamic oscillatory shear measurements were performed on the melt-pressed discs over 
cooling and heating cycles (Figure 4.3).  As observed in the DSC spectra, the glass transition 
temperatures, signified by the peak of the tan delta, of the H-UPy functionalized polymers were 
much higher than the unfunctionalized PETG, and the increase was most significant when 
comparing the polymers of 2000 g mol-1.  When the peaks of the tan delta were plotted against 
the inverse of the molecular weight (Figure 4.4), the unfunctionalized polymers corresponded 
with Fox-Flory theory.30  However, the H-UPy functionalized polymers were not consistent with 
Fox-Flory theory based on their inherent molecular weights.  These polymers all possess 
“operative” molecular weights well above the CME, which are presumably induced from the 
supramolecular, noncovalent bonding of the UPy endgroups.  Although the effect of UPy 
functionalization on Tg decreases with increasing molecular weight, the properties are enhanced 
to levels comparable with the commercial material (Appendix D, Figure D1). 
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Figure 4.3 Dynamic oscillatory shear measurements of the tan delta as the material goes through 
cooling and heating cycles, where the peak signifies the Tg of A) H-UPy functionalized 
materials and B) unfunctionalized PETG (1 Hz, 0.1% strain, parallel plate fixture with plate 
diameter of 8 mm and gap length of 1000 µm). 
	
 
Figure 4.4 The peak of the tan delta plotted against inverse molecular weight (lines added to 
clearly present trends). 
	
	
4.3.2.b Relationship Between Physical, Mechanical, and Surface Properties 
The physical appearance of PETG2k and PETG2k-H-UPy (Figure 4.5) denotes the 
differences observed in the mechanical properties (Figure 4.6).  PETG2k is a brittle, opaque solid; 
however, PETG2k-H-UPy is clear and flexible.  PETG2k displayed features of a highly crystalline 
polymer, with a limited glassy plateau and no crossover between G’ and G” in the glass 
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transition region.  PETG2k-H-UPy showed dramatic improvements in mechanical properties, and 
displayed the overall features of an amorphous plastic.  AFM further confirmed the difference 
between the crystalline and amorphous character of the polymer before and after H-UPy 
functionalization.  Prior to end-functionalization, PETG2k had a surface roughness of 73.4 ±8.1 
nm, while PETG2k-H-UPy had a pristine, smooth surface of 1.2 ±0.3 nm (Figure 4.7).  
Furthermore, Figure 4.6 shows the onset of terminal flow at 110 °C for PETG2k-H-UPy, 
suggesting that UPy-UPy bonds have dissociated and any remaining small crystallites have 
melted by 150 °C. 
 
Figure 4.5 Photograph comparing PETG2k (left) to PETG2k-H-UPy (right). 
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Figure 4.6 Dynamic oscillatory shear measurements depicting the G’ and G” of the materials 
through cooling and heating cycles (1 Hz, 0.1% strain, parallel plate fixture with plate diameter 
of 8 mm and gap length of 1000 µm). 
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Figure 4.7 RMS surface roughness of PETG before and after H-UPy functionalization.  RMS 
surface roughness obtained from AFM images (20x20 µm) using Nanoscope 6.14R1 software. 
 
Dynamic rheology and AFM showed similar, though less pronounced, trends when 
looking at materials of 3800 and 6800 g mol-1 (Figures 4.6 and 4.7, respectively).  Because these 
polymers are of higher molecular weight, they have fewer endgroups and therefore, a lower 
concentration of UPy groups within the system.  Furthermore, because these materials are near 
the CME, the properties of the unfunctionalized polymers are improved as compared with 
PETG2k.  However, regardless of inherent molecular weight, the elastic moduli of the H-UPy 
functionalized materials were improved over the moduli of the virgin polymers. The H-UPy 
functionalized polymers maintained a high elastic modulus over a broad temperature range, 
comparable to commercial-grade PETG (Appendix D, Figure D2).  Interestingly, an extended 
plateau was observed before reaching the terminal flow regime when looking at PETG6.8k-H-
UPy.  This behavior is believed to be due to the increased inherent molecular weight of the 
polymer, causing slower reptation and stress-relaxation.   
After H-UPy functionalization of PETG3.8k, which had an RMS surface roughness of 24.2 
±0.7 nm, PETG3.8k-H-UPy resulted in a smooth surface with RMS surface roughness of 3.9 ±0.4 
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nm.  Materials of 6800 g mol-1 showed no significant differences in surface roughness because 
the unfunctionalized material is above the CME.31  Furthermore, the surface roughness of the H-
UPy functionalized materials were all comparable to that of commercial PETG (Figure D3, 
Appendix D).  Other surface properties, such as static water-in-air contact angle, did not show 
any significant difference when comparing the functionalized and unfunctionalized materials, 
suggesting that the UPy endgroups do not aggregate at the surface of the polymer film (Figure 
C29, Appendix C). 
4.3.2.c Viscosity in the Melt 
Figure 4.8 displays the effect of the H-UPy endgroup and molecular weight on melt 
viscosity.  The melt viscosity of PETG2k-H-UPy was 34 times higher than that of PETG2k at 87 
°C.  At 100 °C, the viscosity of PETG2k-H-UPy dramatically decreased, and the viscosity 
matched the viscosity of PETG2k by 110 °C, confirming dissociation of UPy-UPy aggregates.  
Furthermore, the viscosity of PETG2k-H-UPy and PETG3.8k-H-UPy was much lower than the 
viscosity of commercial PETG (Figure 4.9 and Figure D4, Appendix D).  At 150 °C, the 
viscosity of PETG2k-H-UPy (1620 Pa.s) was 56 times lower than commercial PETG (91,200 
Pa.s), and PETG3.8k-H-UPy (13,100 Pa.s) was 7 times lower.  This is significant, as these 
materials serve as the first example of engineering polymers with improved thermal and 
mechanical properties, as well as improved flow characteristics at pertinent temperatures, well 
below the onset of UPy degradation.  Thus, the reduced thermal stability of the UPy endgroup by 
TGA (Table 4.1 and Table 4.2) does not affect the thermal stability of the final product at 
temperatures of use or processing. 
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Figure 4.8 Effect of H-UPy endgroup structure and molecular weight on melt viscosity.  
Rheological characterization of PETG and PETG-H-UPy at 2000, 3800, and 6800 g mol-1 (shear 
rate 0.05 s-1, parallel plate fixture with plate diameter of 8 mm and gap length of 1000 µm). 
 
80 90 100 110 120 130 140 150 160
0
1x106
2x106
3x106
4x106
5x106
6x106
7x106
8x106
9x106
1x107
Vi
sc
os
ity
 (P
a.
s)
Temperature (°C)
 Commercial PETG
 
Figure 4.9 Rheological characterization of commercial PETG (shear rate 0.05 s-1, parallel plate 
fixture with plate diameter of 8 mm and gap length of 1000 µm). 
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NMR) was performed on PETG6.8k-H-UPy from 25-100 °C (Figure 4.10).  The strength of 
intermolecular quadruple hydrogen bonding decreased by 65 °C, which was observed through 
weakened signals at 11.3 and 13.1 ppm.  Dissociation occurred circa 80 °C, with complete 
dissociation occurring by 100 °C as the signals disappeared.  The weakening and disappearance 
of the signals at 11.3 and 13.1 ppm changed at similar temperatures when looking at the VT-
NMR spectra of PETG2k-H-UPy, further confirming that the extended rubbery plateau is due to 
interactions in the bulk, melt state of the higher molecular weight polymer (Figure C30, 
Appendix C). 
 
 
Figure 4.10 Variable temperature 1H NMR spectra of PETG6.8k-H-UPy in TCE-d2 (c = 5 mM, 
600 s equilibrium allowed at each temperature).  The box outlines peaks that signify the presence 
of intermolecular H-bonding of UPy endgroups. 
 
The viscosity of the materials was observed over several frequencies (1-600 s-1) at 
temperatures just above the UPy-UPy dissociation temperature, 90 and 120 °C (Table 4.3 and 
Figures C31-C34 in Appendix C).  At these temperatures, the H-UPy functionalized materials 
experience a dramatic decrease in viscosity, where the difference in viscosity (Dη*) was 
	 105 
calculated by (η*90 °C)/(η*120 °C) at 600 s-1.  The materials begin at viscosities that are much 
higher than the corresponding unfunctionalized precursors, thus the large decrease in viscosity of 
the H-UPy functionalized materials suggests the dissociation of UPy-UPy aggregates.  UPy 
dissociation is also presumed because the temperature range observed in the experiment was near 
the dissociation temperature of UPy-UPy aggregates, as reported in previous literature and seen 
in the VT-NMR experiments in Figure 4.10 and Figure C30 of Appendix C.19  At 120 °C, the 
viscosity of the UPy functionalized materials is approximately the same as the viscosity of the 
unfunctionalized polymers of the same molecular weight (i.e., materials of 3,800 g mol-1 and 
6,800 g mol-1).  Surprisingly, the viscosity of PETG2k-H-UPy was much lower than the viscosity 
of PETG2k at 120 °C.  It is suspected, based on the crystalline character of the PETG2k observed 
in Figures 4.5 and 4.6, that the viscosity of PETG2k remained higher at 120 °C due to lingering 
crystallites. 
The drop in viscosity of the H-UPy functionalized polymers, however, is similar to the 
drop in viscosity observed in the commercial material (Table 4.3).  Therefore, it is unclear if this 
drop is due solely to UPy-UPy dissociation or due to the fact that these polymers take on the 
more amorphous properties of the high molecular weight material.  A combination of both 
rationales is likely, as it is clear that Dη* increases in unfunctionalized PETG with increasing 
molecular weight (i.e., as the polymers approach the CME). 
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Table 4.3 Viscosity Change from 90 °C to 120 °C at 600 s-1. 
Polymer η*90 °C η*120 °C Dη* (Pa.s) 
PETG2k 79,500 20,400 4 
PETG2k-H-UPy 163,700 3,000 54 
PETG3.8k 45,100 4,000 12 
PETG3.8k-H-UPy 172,300 4,000 48 
PETG6.8k 56,200 2,800 20 
PETG3.8k-H-UPy 199,800 4,000 51 
Commercial PETG 217,300 4,000 55 
 
 
4.3.2.d Tensile Testing 
 Finally, tensile testing was performed to measure the elongation at break and overall 
toughness of the engineering plastics.  As shown in Figure 4.5 and Figure 4.6, PETG2k had 
nearly no mechanical integrity and broke almost immediately upon stretching (Figure 4.11).  
Figure 4.11B more clearly shows the lack of mechanical integrity of PETG2k, since the sample 
broke almost immediately upon elongation, making it difficult to identify in Figure 4.11A.  
PETG2k-H-UPy showed dramatic improvements in tensile properties.  The strain at break of 
PETG2k-H-UPy was comparable to PETG6.8k when looking at the average of five samples 
(Figure 4.11B).  In addition to the elongation at break, the tensile strength of PETG2k-H-UPy (48 
±14 MPa at yield) was approximately two times greater than the tensile strength of PETG2k (26 
±8 MPa at yield) and comparable to PETG6.8k (39 ±6 MPa at yield).  Thus, PETG2k-H-UPy 
performed comparably to a polymer at least three times its own base molecular weight (Figure 
D5, Appendix D).  Significant improvements were also seen in the elongation at break of 
PETG3.8k-H-UPy as compared to PETG3.8k.  The improvements observed in the tensile properties 
of PETG2k-H-UPy and PETG3.8k-H-UPy, along with the viscoelastic improvements observed in 
Figure 4.8, show that these polymers not only have improved processing capabilities but also 
have fundamental mechanical robustness. 
	 107 
 
Figure 4.11 A) Stress–strain curves of PETG and PETG-H-UPy of 2000, 3800, and 6800 g mol-1 
at 10 mm min-1, and B) average strain at break of the materials over five samples. 
 
4.4 Conclusions 
Two synthetic strategies were utilized to end-functionalize engineering polymers with the 
UPy endgroup, thus delineating the adaptability of supramolecular functionalization of a robust 
polymer system.  The synthetic method was dependent on the rigidity of the linker connecting 
the UPy moiety to the polymer terminus, varying from linear to bicyclic.  An increase in Tg was 
observed regardless of endgroup structure. 
Endgroup functionalization of PETG of different molecular weights was also explored 
utilizing polymers well below and near the CME.  Property changes were most substantial in 
polymers of the lowest molecular weight (2000 g mol-1).  Materials of higher molecular weights 
(3800 and 6800 g mol-1) showed less pronounced changes in thermal, mechanical, and 
viscoelastic properties.  Notably, however, the higher molecular weight materials properties were 
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enhanced to levels of performance similar to commercial PETG (comparison of these materials 
to the commercial polymer can be found in Appendix D, Figures D1-D5). 
The enhancement of materials properties of PETG2k-H-UPy were remarkable.  The 
thermal properties of PETG2k-H-UPy were comparable to high molecular weight, commercial-
grade PETG, displaying a 28 °C increase in Tg over PETG2k after melt-processing.  The tensile 
performance was comparable to materials greater than three times the base molecular weight of 
2000 g mol-1.  Furthermore, the melt-viscosity of PETG2k-H-UPy dropped to match the low 
viscosity of PETG2k at 110 °C.  Due to the unique thermal properties of PETG and the utilization 
of elegant supramolecular chemistry, an engineering polymer was designed to exhibit robust 
mechanical properties at room temperature and a high Tg, thus an adequate theoretical “use 
temperature range”.  Additionally, this material exhibited a low melt viscosity at a suitable 
temperature for safe, non-degradative processing.  While future endeavors may explore even 
lower molecular weight prepolymers and other uniquely adequate, high-performing polymer 
systems, this study gives a practical example of a supramolecularly improved industrially 
relevant polymer. 
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APPENDIX A: SUPPLEMENTARY INFORMATION FOR CHAPTER 2 
 
IODINATED HOMOPOLYMERS AS A VERSATILE PLATFORM FOR RADIOPAQUE 
BIOMATERIALS AND NANOPARTICLES 
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Table A1. EDS Results from 2,2-Bis(iodomethyl)-1,3-propanediol. 
Element Wt% 
C 16.97 
H 2.83 
I 70.75 
O 9.04 
N 0.00 
 
 
 
 
Table A2.  XPS Results from 2,2-Bis(iodomethyl)-1,3-propanediol. 
 
Element Atomic Mass Atomic Concentration (%) Mass Concentration (%) 
C 12.011 66.71 27.15 
I 126.904 14.58 62.71 
O 15.999 18.70 10.14 
Br 79.904 0.00 0.00 
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Figure A1. 1H NMR of 2,2-bis(iodomethyl)-1,3-propanediol (HDO, H2O residual peaks). 
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Figure A2. 13C NMR of 2,2-bis(iodomethyl)-1,3-propanediol. 
 
	 115 
 
Figure A3. 1H NMR of the succinic acid based prepolymer. 
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Figure A4. 1H NMR of the adipic acid based prepolymer. 
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Figure A5. 1H NMR of the sebacic acid based prepolymer. 
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Figure A6. DSC of the succinic acid based prepolymer. 
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Figure A7. DSC of the adipic acid based prepolymer. 
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Figure A8. DSC of the sebacic acid based prepolymer. 
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Figure A9. 1H NMR of the methacrylate endcapped succinic acid based prepolymer. 
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Figure A10. 1H NMR of the methacrylate endcapped adipic acid based prepolymer. 
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Figure A11. 1H NMR of the methacrylate endcapped sebacic acid based prepolymer. 
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Figure A12. DSC of the succinic acid based thermoset. 
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Figure A13. DSC of the adipic acid based thermoset. 
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Figure A14. DSC of the sebacic acid based thermoset. 
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Table A3. Properties of Iodinated Thermosets Used in Instron Experiments. 
 
Polymer (by 
diacid) Mn (g mol
-1)a PDIb Tg (°C)c 5% (°C)
d 
Succinic 7300 1.38 16.5 284 
Adipic 7770 1.49 6.4 280 
Sebacic 8700 1.38 -14.0 310 
 
a Determined by 1H NMR before crosslinking, b Determined by GPC before 
crosslinking, c DSC, second heat 10 °C min-1, d Decomposition measured by 
TGA 20 °C min-1. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure A15. Photos displaying minimal discoloration after crosslinking the films.  Films listed 
by diacid from left to right: Succinic, Adipic, Sebacic. 
 
 
 
 
 
 
Table A4. DLS Results of Nanoparticles Formulated Without PEG. 
 
Size (d.nm) PDI 
450.3 0.01 
434.2 0.02 
428.9 0.07 
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Figure A16.  Graph displaying the attenuation measured in the heart, lungs, liver, spleen, and 
kidneys from the time of injection of Omnipaque® (iohexol) and every 5 minutes until reaching 
30 minutes. 
 
 
 
 
 
 
Figure A17.  Graph displaying the attenuation measured in the heart, lungs, liver, spleen, and 
kidneys from the time of injection of the adipic acid based nanoparticles (NPs), every 5 minutes 
until reaching 30 minutes, and again after 60 minutes. 
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Figure A18.  Images obtained from slides made using the lungs of the mouse injected with 
nanoparticles (A at 10x and B at 40x) and the lungs of the control mouse (no contrast agent 
injected, C at 10x and D at 40x). 
  
A)
B)
C)
D)
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APPENDIX B: SUPPLEMENTARY INFORMATION FOR CHAPTER 3 
 
RADIOPAQUE SHAPE MEMORY MATERIALS VIA IODINATED COPOLYESTERS 
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Scheme B1.  Iodinated monomer, 2,2-bis(iodomethyl)-1,3-propanediol.  Yield:  74%; T.Y. 67.6 
g; A.Y. 49.9 g 
 
 
 
 
Table B1.  Properties of 2,2-Bis(iodomethyl)-1,3-propanediol Determined by DSC and TGA. 
 
Tm (°C) ΔH (J/g) 5% (°C) 10% (°C) 
130 104 201 216 
 
 
 
 
 
 
 
 
HO OH
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Figure B1.  DSC (ramp at 10 °C min-1) spectrum of 2,2-bis(iodomethyl)-1,3-propanediol. 
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Figure B2.  TGA (ramp at 20 °C min-1) spectrum of 2,2-bis(iodomethyl)-1,3-propanediol. 
 
 
 
 
 
 
 
 
 
Table B2.  Elemental Analysis of 2,2-Bis(iodomethyl)-1,3-propanediol Determined by XPS.   
 
Peak 
Mass 
Concentration 
(%) 
Atomic 
Concentration 
(%) 
I 60.25 13.26 
O 9.89 17.27 
C 29.86 69.47 
Br 0.00 0.00 
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Figure B3.  1H NMR spectrum of the prepolymer with a target of 15 mole percent iodinated 
monomer. 
 
 
 
Example of how molecular weight is calculated using Figure B3:   
1.00 / (0.01 + 0.03) = 25 repeat units 
25 * 0.11 = 2.75 (representative of iodinated repeat units) 
2.75 * 466.05 g mol-1 = 1300 g mol-1  (MW of total iodinated units in polymer) 
22.25 * 256.34 g mol-1 = 5700 g mol-1 (MW of total octanediol-based units in polymer) 
1300 g mol-1 + 5700 g mol-1 = 7000 g mol-1 (MW of polymer) 
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Figure B4.  1H NMR spectrum of the prepolymer with a target of 20 mole percent iodinated 
monomer 
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Figure B5.  1H NMR spectrum of the prepolymer with a target of 25 mole percent iodinated 
monomer 
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Figure B6.  1H NMR spectrum of the prepolymer with a target of 35 mole percent iodinated 
monomer 
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Figure B7.  GPC: 15 mol% I (number value depicts <Mp>). 
 
 
 
 
 
 
 
Figure B8.  GPC: 20 mol% I (number value depicts <Mp>). 
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Figure B9.  GPC: 25 mol% I (number value depicts <Mp>). 
 
 
 
 
 
 
 
 
Figure B10.  GPC: 35 mol% I (number value depicts <Mp>). 
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Figure B11.  DSC:  15 mol% I prepolymers. 
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Figure B12.  DSC:  20 mol% I prepolymers. 
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Figure B13.  DSC:  25 mol% I prepolymers. 
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Figure B14.  DSC:  35 mol% I prepolymers. 
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Figure B15.  Example of the 1H NMR spectrum after end-functionalizing the prepolymer with a 
target of 20 mole percent of the iodinated monomer.  The peaks at 6.12 and 5.61 ppm indicate 
the addition of the methacrylate endgroup. 
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Figure B16.  DSC:  15 mol% I thermoset. 
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Figure B17.  DSC:  20 mol% I thermoset. 
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Figure B18.  DSC:  25 mol% I thermoset. 
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Figure B19.  DSC:  35 mol% I thermoset. 
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Figure B20.  DMA showing the storage modulus from 0-60 °C of an average of three samples 
for each mole percentage of iodinated monomer incorporated into the crosslinked copolymer 
films. 
 
 
 
Table B3.  Weight Percent Iodine Found by EDS. 
Target mole percent I 
monomer (%) 
Prepolymer weight 
percent iodine (%) 
Crosslinked film weight 
percent iodine (%) 
15 37 ±3 32 ±1 
20 36 ±4 30 ±2 
25 48 ±2 38 ±1 
35 61 ±7 55 ±2 
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Table B4.  EDS 15 mol% I Prepolymer (3 Samples). 
 
Atom Weight percent (%) 
Atomic percent 
(%) 
C  40.85 71.81 
O  15.88 20.96 
Sn  3.15 0.56 
I  40.13 6.68 
C  40.93 68.39 
O  20.29 25.46 
Sn  1.83 0.31 
I  36.94 5.84 
C  41.16 67.3 
O  21.96 26.96 
Sn  2.42 0.4 
I  34.47 5.33 
 
 
 
 
 
Table B5.  EDS 20 mol% I Prepolymer (3 Samples). 
 
Atom Weight percent (%) 
Atomic percent 
(%) 
C 43.58 67.96 
O 23.16 27.11 
Sn 1.93 0.3 
I 31.34 4.63 
C 40.24 69.09 
O 18.79 24.22 
Sn 2.37 0.41 
I 38.6 6.27 
C 38.67 66.56 
O 20.72 26.78 
Sn 3.44 0.6 
I 37.17 6.06 
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Table B6.  EDS 25 mol% I Prepolymer (3 Samples). 
 
Atom Weight percent (%) 
Atomic percent 
(%) 
C  30.47 62.32 
O 18.03 27.68 
Sn 2.52 0.52 
I 48.98 9.48 
C  32.71 66.73 
O 15.13 23.17 
Sn 2.41 0.5 
I 49.75 9.61 
C  34.25 66.21 
O 17.13 24.86 
Sn 2.55 0.5 
I 46.07 8.43 
 
 
 
 
 
Table B7.  EDS 35 mol% I Prepolymer (3 Samples). 
 
Atom Weight percent (%) 
Atomic percent 
(%) 
C  25.23 66.69 
O 8.39 16.64 
Sn 3.51 0.94 
I 62.87 15.73 
C  21.09 62.61 
O 7.78 17.33 
Sn 3.68 1.11 
I 67.46 18.96 
C  31.34 67.55 
O 13.03 21.07 
Sn 2.24 0.49 
I 53.39 10.89 
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Table B8.  EDS 15 mol% I Film (3 Samples). 
 
Atom Weight percent (%) 
Atomic percent 
(%) 
C  47.76 74.87 
O  16.52 19.45 
Sn  2.35 0.37 
I  32.43 4.81 
C  47.02 72.9 
O  18.67 21.73 
Sn  2.01 0.31 
I  31.49 4.62 
C  48.02 74.01 
O  17.87 20.68 
Sn  1.88 0.29 
I  31.39 4.58 
 
 
 
 
 
Table B9.  EDS 20 mol% I Film (3 Samples). 
 
Atom Weight percent (%) 
Atomic percent 
(%) 
C  51.1 77.59 
O 15.19 17.31 
Sn 2.78 0.43 
I 30.33 4.36 
C  47.33 73.88 
O 17.87 20.95 
Sn 2.71 0.43 
I 32.09 4.74 
C  51.96 76.26 
O 17.48 19.26 
Sn 2.11 0.31 
I 27.84 3.87 
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Table B10.  EDS 25 mol% I Film (3 Samples). 
 
Atom Weight percent (%) 
Atomic percent 
(%) 
C  45.24 75.79 
O 14.1 17.74 
Sn 2.61 0.44 
I 38.05 6.03 
C  43.93 74.65 
O 14.62 18.65 
Sn 2.69 0.46 
I 38.76 6.23 
C  45.45 75.54 
O 14.53 18.13 
Sn 2.63 0.44 
I 37.4 5.88 
 
 
 
 
 
Table B11.  EDS 35 mol% I Film (3 Samples). 
 
Atom Weight percent (%) 
Atomic percent 
(%) 
C  32.15 72.38 
O 8.88 15 
Sn 4.15 0.94 
I 54.83 11.68 
C  29.67 70.17 
O 9.05 16.06 
Sn 3.67 0.88 
I 57.61 12.89 
C  32.64 72.42 
O 8.98 14.95 
Sn 4.35 0.98 
I 53.47 11.23 
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Figure B21.  Photo depicting minimal discoloration due to UV curing.  From left to right:  PCL, 
35%I, 25%I, 15%I. 
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APPENDIX C: SUPPLEMENTARY INFORMATION FOR CHAPTER 4 
 
SUPRAMOLECULAR ENGINEERING POLYESTERS:  ENDGROUP 
FUNCTIONALIZATION OF GLYCOL MODIFIED PET WITH UREIDOPYRIMIDINONE 
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Figure C1.  1H NMR spectrum of H-UPy in CDCl3 at ambient temperature.  1H NMR (400 
MHz, CDCl3) δ: 13.10 (s, 1H), 11.85 (s, 1H), 10.18 (s, 1H), 5.81 (s, 1H), 3.28 (t, 2H), 3.25 (t, 
2H), 2.22 (s, 3H), 1.61 (m, 4H), 1.40 (m, 4H). 
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Figure C2.  1H NMR spectrum of CH-UPy in CDCl3 at ambient temperature. 
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Figure C3.  1H NMR spectrum of PETG2k in CDCl3 at ambient temperature. The ratio of the 
integrals of the aromatic repeating unit (1.00) to the added integrals of the PETG peaks µ 
hydroxyl endgroups (0.10) was taken to find Xn. 
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Figure C4.  1H NMR spectrum of PETG2k-D-UPy in CDCl3 at ambient temperature.  The ratio 
of the integrals of the aromatic repeating unit (1.00) to the added integrals of the PETG peaks µ 
to the UPy endgroups and µ to existing hydroxyl endgroups (0.10) was taken to find Xn. 
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Figure C5.  1H NMR spectrum of PETG2k-CH-UPy in CDCl3 at ambient temperature.  The ratio 
of the integrals of the aromatic repeating unit (1.00) to the added integrals of the PETG peaks µ 
to the UPy endgroups and µ to existing hydroxyl endgroups (0.10) was taken to find Xn. 
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Figure C6.  1H NMR spectrum of PETG2k-H-UPy in CDCl3 at ambient temperature. The ratio of 
the integrals of the aromatic repeating unit (1.00) to the added integrals of the PETG peaks µ to 
the UPy endgroups and µ to existing hydroxyl endgroups (0.07) was taken to find Xn. 
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Figure C7.  1H NMR spectrum of PETG3.8k in CDCl3 at ambient temperature.  
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Figure C8.  1H NMR spectrum of PETG3.8k-H-UPy in CDCl3 at ambient temperature. 
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Figure C9.  1H NMR spectrum of PETG6.8k in CDCl3 at ambient temperature.  
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Figure C10.  1H NMR spectrum of PETG6.8k-H-UPy in CDCl3 at ambient temperature. 
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Figure C11.  ATR FT-IR spectra of CH-UPy, PETG2k-CH-UPy, and PETG2k.  The full spectra, 
on the left, depict the disappearance of the hydroxyl endgroup of PETG as well as the 
disappearance of the isocyanate functionality of CH-UPy. 
 
 
 
 
Figure C12.  ATR FT-IR spectra of PETG2k-D-UPy and PETG2k.  Peaks characteristic of the 
ureido endgroup are outlined in the spectra on the left.  The full spectra, on the right, depict the 
disappearance of the hydroxyl endgroup of PETG.  
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Figure C13.  GPC traces of PETG2k, PETG2k-CH-UPy (left), and PETG2k-D-UPy (right). 
 
 
 
Figure C14.  TGA spectra of PETG2k (black) compared to PETG2k-CH-UPy (blue). 
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Figure C15.  TGA spectra of PETG2k (black) compared to PETG2k-D-UPy (blue). 
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Figure C16.  DSC spectra of PETG2k-CH-UPy (red) and PETG2k-D-UPy (blue). 
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Figure C17.  GPC traces of PETG before and after H-UPy functionalization. 
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Figure C18.  TGA spectra of all of the materials functionalized with H-UPy (dotted lines) 
compared to the unfunctionalized materials (solid lines). 
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Figure C19.  1H NMR spectrum of PETG2k (red) and PETG2k-H-UPy before processing (“raw”, 
green), and after melt pressing (“pressed”, blue) in CDCl3 at ambient temperature. 
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Figure C20.  1H NMR spectrum of PETG3.8k (red) and PETG3.8k-H-UPy before processing 
(“raw”, green), and after melt pressing (“pressed”, blue) in CDCl3 at ambient temperature. 
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Figure C21.  1H NMR spectrum of PETG6.8k (red) and PETG6.8k-H-UPy before processing 
(“raw”, green), and after melt pressing (“pressed”, blue) in CDCl3 at ambient temperature. 
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Figure C22.  FT-IR Spectra comparing PETG and PETG-H-UPy of 2000 g mol-1 before melt 
processing. 
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Figure C23.  FT-IR Spectra comparing PETG and PETG-H-UPy of 2000 g mol-1 after melt 
processing. 
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Figure C24.  FT-IR Spectra comparing PETG and PETG-H-UPy of 3800 g mol-1 before melt 
processing. 
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Figure C25.  FT-IR Spectra comparing PETG and PETG-H-UPy of 3800 g mol-1 after melt 
processing. 
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Figure C26.  FT-IR Spectra comparing PETG and PETG-H-UPy of 6800 g mol-1 before melt 
processing. 
 
 
 
 
PETG6.8k Raw
PETG6.8k-H-UPy Raw
	 180 
 
Figure C27.  FT-IR Spectra comparing PETG and PETG-H-UPy of 6800 g mol-1 after melt 
processing. 
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Figure C28.  AFM 20x20 µm images:  A) PETG2k, B) PETG2k-H-UPy, C) PETG3.8k, D) 
PETG3.8k-H-UPy, E) PETG6.8k, F) PETG6.8k-H-UPy. 
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Figure C29.  Contact angle of all of the materials.   
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Figure C30.  Variable temperature 1H NMR spectra of PETG2k-H-UPy in TCE-d2 (c = 5 mM, 
600 s equilibrium allowed at each temperature).  The box outlines peaks that signify the presence 
of intermolecular H-bonding of UPy endgroups. Temperatures go from 20 °C (red, bottom 
spectrum) to 100 °C (purple, top spectrum).  
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Figure C31.  Frequency sweep displaying the complex viscosity of PETG and H-UPy 
functionalized PETG at 90 and 120 °C.   
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Figure C32.  Frequency sweep displaying the complex viscosity of PETG and H-UPy 
functionalized PETG at 90 and 120 °C.   
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Figure C33.  Frequency sweep displaying the complex viscosity of PETG and H-UPy 
functionalized PETG at 90 and 120 °C.   
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Figure C34.  Frequency sweep displaying the complex viscosity of commercial-grade PETG at 
90 and 120 °C.   
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APPENDIX D: SUPPLEMENTARY INFORMATION FOR CHAPTER 4—
COMMERCIAL COMPARISONS 
 
SUPRAMOLECULAR ENGINEERING POLYESTERS:  ENDGROUP 
FUNCTIONALIZATION OF GLYCOL MODIFIED PET WITH UREIDOPYRIMIDINONE 
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COMMERCIAL COMPARISONS 
 
 
 
Figure D1.  Comparing tan delta of low MW polymers before and after UPy functionalization 
with Commercial PETG. 
 
 
 
 
Figure D2.  Comparison of G’ of low MW polymers before and after UPy functionalization with 
Commercial PETG. 
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Figure D3.  Comparison of the RMS surface roughness of low MW polymers before and after 
UPy functionalization with Commercial PETG (17.2 kg mol-1). 
 
 
 
Figure D4.  Comparison of melt viscosity of low MW, H-UPy functionalized polymers and 
Commercial PETG (Comm PETG). 
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Figure D5.  Comparison of the maximum strain at break of five samples of low MW polymers 
before and after UPy functionalization with Commercial PETG (17.2 kg mol-1).   
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